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The metabotropic glutamate receptors (mGluRs) form a family of neuromodulatory G protein-coupled 
receptors that contain both a seven-helix transmembrane domain (TMD) and a large extracellular ligand-
binding domain (LBD) which enables stable dimerization. While numerous studies have revealed 
variability across subtypes in the initial activation steps at the level of LBD dimers, an understanding of 
inter-TMD interaction and rearrangement remains limited. Here we use a combination of single molecule 
fluorescence, molecular dynamics, functional assays, and conformational sensors to reveal that distinct 
TMD assembly properties drive differences between mGluR subtypes. We uncover a variable region within 
transmembrane helix 4 (TM4) that contributes to homo- and heterodimerization in a subtype-specific 
manner and tunes orthosteric, allosteric and basal activation. We also confirm a critical role for a conserved 
inter-TM6 interface in stabilizing the active state during orthosteric or allosteric activation. Together this 
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 Assembly into multi-subunit complexes is an essential aspect of many membrane receptors. 
Dimerization or higher-order oligomerization can shape the ligand sensitivity or signaling dynamics of a 
protein complex by producing various forms of allostery and cooperativity or mediate the formation of 
binding, functional, or regulatory sites (Changeux and Christopoulos, 2016, Katzung, 2004). In many cases, 
the formation of a multi-subunit complex is required for function. For example, ligand-gated ion channels 
require multiple subunits to form a functional pore, making assembly into complexes an absolute necessity. 
In the case of the vast superfamily of G protein-coupled receptors (GPCRs) the role of quaternary structure 
has remained more enigmatic. The proposed dimerization of family A GPCRs, such as rhodopsin or the 
beta-adrenergic receptors, has sparked intense debate based on the wide range of results that are seen across 
techniques and preparations (Ferré et al., 2014, Milligan et al., 2019, Sleno and Hébert, 2019). However, a 
reasonable interpretation of the litany of studies is that dimerization can indeed occur and contribute to 
various modes of regulation of family A GPCR function, but is likely transient, based on single molecule 
imaging studies (Hern et al., 2010, Kasai et al., 2011, Meral et al., 2018, Işbilir et al., 2020, Möller et al., 
2020, Felce et al., 2017), and is not required for G protein activation, based on reconstitution studies 
(Bayburt et al., 2007, Whorton et al., 2008, Whorton et al., 2007, Kuszak et al., 2009). Importantly, a 
structural understanding of GPCR dimerization has remained elusive with a wide range of dimer interfaces 
proposed for different GPCRs based on cross-linking, mutagenesis and x-ray crystallography data. More 
recently, the concept of dynamic, “rolling” inter-subunit interfaces which inter-change and are associated 
with different functional states has emerged as a possible explanation for the seemingly incompatible results 
seen across studies (Gurevich and Gurevich, 2008, Meral et al., 2018, Sleno and Hébert, 2019, Dijkman et 
al., 2018, Jin et al., 2018). Crucially, dimerization is likely best taken on a case-by-case basis where different 
dimerization propensities, modes and functional effects are expected for each subtype across the large 
superfamily of GPCRs.  
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 One major exception to the secondary, modulatory role for dimerization in the function of GPCRs 
are the family C GPCRs, including the metabotropic glutamate receptors (mGluRs) and a number of other 
subfamilies (Ellaithy et al., 2020). The family C GPCRs contain canonical seven-helix transmembrane 
domains (TMDs) but are distinguished by their large, bi-lobed, extracellular ligand binding domains 
(LBDs), which are essential for their constitutive homo- and hetero-dimerization (Romano et al., 1996, 
Doumazane et al., 2011, Levitz et al., 2016, Lee et al., 2020). Unlike family A GPCRs, reconstituted 
mGluR2 monomers are unable to undergo glutamate-mediated G protein activation (El Moustaine et al., 
2012), although they can be activated by TMD-targeting allosteric drugs. In response to orthosteric agonists, 
mGluR LBD dimers undergo dramatic rearrangement between conformations which both reshape and are 
controlled by a complex inter-LBD dimer interface, as deciphered through crystallographic (Kunishima et 
al., 2000, Tsuchiya et al., 2002, Muto et al., 2007) and spectroscopic (Levitz et al., 2016, Vafabakhsh et al., 
2015, Olofsson et al., 2014) studies. However, how such motions are transmitted to the TMDs, how TMDs 
can be activated directly by allosteric drugs and the role of associated inter-TMD interactions in this family 
of receptors remains unclear, although a variety of recent studies have provided insight. 
 A series of Förster resonance energy transfer (FRET) studies of full-length mGluR1 have shown 
that glutamate and other agonists produce relative motions between the TMDs that occur on fast millisecond 
time scales that precede receptor activation (Hlavackova et al., 2012, Marcaggi et al., 2009, Grushevskyi et 
al., 2019, Tateyama et al., 2004, Tateyama and Kubo, 2006). Structural interpretation of such studies has 
been limited but the consistently observed FRET efficiency increase seen with intersubunit sensors points 
to a rearrangement that leads to increased inter-TMD interaction upon LBD activation. Notably, we recently 
developed an isolated TMD FRET sensor which showed that TMD-targeting allosteric drugs are able to 
produce intersubunit re-arrangements autonomously without allosteric input from the LBDs (Gutzeit et al., 
2019), pointing to a multi-state model of inter-TMD interaction and raising questions about TMD 
rearrangement in response to allosteric versus orthosteric activation. In line with this, a prior cross-linking 
study of full-length mGluR2 provided evidence for close proximity of TM4 and TM5 helices in inactive 
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states and TM6 helices in active states (Xue et al., 2014). Despite such studies, the relative strength of inter-
TMD interactions within mGluR dimers remains unknown. High resolution structural studies have provided 
further insight but no clear consensus regarding TMD interfaces. Crystal structures of isolated mGluR1 
(Wu et al., 2014) and mGluR5 (Dore et al., 2014) TMDs have shown TM1-mediated dimerization or 
monomers, respectively, while a cryogenic electron microscopy (cryo-EM) study of full-length mGluR5 
(Koehl et al., 2019) showed no TMD interface in an inactive nanodisc-reconstituted form but a clear TM6 
interface in a glutamate and positive allosteric modulator-bound pre-active state. Finally, a series of cryo-
EM studies of the related GABAB receptors showed a lipid-mediated inactive TM5 interface that re-
arranged to a TM6 interface in the presence of agonist and a positive allosteric modulator (Mao et al., 2020, 
Papasergi-Scott et al., 2020, Park et al., 2020, Shaye et al., 2020). Together these studies point to a role for 
TMD rearrangement in mGluR activation, but the steps prior to formation of a putative active TM6 interface 
are not clear. 
Recent work has also revealed deep conformational heterogeneity between mGluR subtypes at the 
level of the LBDs that shape the relative activation properties of different homo- and hetero-dimers (Levitz 
et al., 2016, Vafabakhsh et al., 2015, Habrian et al., 2019). Such findings are in line with the notion that the 
eight mGluR subtypes are fine-tuned for their distinct roles within the synapse that require unique glutamate 
sensitivity, activation kinetics and other signaling properties (Reiner and Levitz, 2018). This raises the 
possibility that such variability between subtypes also exists at the TMDs and can be used as a lens to 
dissect the TMD activation mechanism. Intriguingly, we recently used a single molecule imaging approach 
to determine that while all isolated mGluR TMDs tested show a clear propensity for dimerization, the 
mGluR2 subtype shows substantially higher dimerization propensity than other subtypes (Gutzeit et al., 
2019), providing a jumping off point for this study.  
Here, we use a combination of optical, functional and computational techniques to dissect the role 
of inter-TMD interaction in mGluR dimerization and activation with a focus on the highly homologous 
group II mGluRs. Single molecule fluorescence subunit counting experiments reveal that the TMD 
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mediates differences in dimer assembly between mGluR2 and mGluR3. Using observations from coarse-
grained (CG) molecular dynamics (MD) simulations in conjunction with sequence analysis, mutagenesis, 
and subunit counting, we isolate this effect to specific residues at the cytoplasmic end of transmembrane 
helix 4 (TM4). Functional experiments demonstrate that TM4 residues play a modulatory role in both 
orthosteric and allosteric activation of group II mGluRs and controlling basal activity. Using new inter-
TMD FRET sensors in full-length mGluRs, we characterize how orthosteric drugs, allosteric modulators 
and TM4 residues influence the relative TMD conformational dynamics of group II mGluRs. Further, we 
demonstrate that activation associated inter-TMD dynamics involve reorientation away from a TM4 
inactive interface toward a TM6 active interface by employing single molecule subunit counting 
experiments in the presence of ligands. Finally, we find that inter-TMD affinity shows an intermediate level 
in mGluR2/3 heterodimers compared to the homodimers, supporting the role of TMD interactions as 
mediators of the molecular diversity of mGluRs. Together these results, in combination with existing 
literature, lead us to propose a three-step mechanism for mGluR activation that considers the role of 
subtype-specific residues in the TMD that contribute to the functional diversity of mGluR subtypes.   
 
Results: 
The transmembrane domain mediates differences in dimerization between metabotropic glutamate 
receptors 
Motivated by our recent finding that isolated mGluR TMDs are able to dimerize to variable levels 
in the absence of extracellular domains (Gutzeit et al., 2019), we first sought to further understand the 
molecular basis of mGluR TMD dimerization using single molecule pulldown (SiMPull). In this technique, 
detergent-solubilized receptor complexes are isolated from fresh cell lysate and sparsely immobilized via 
antibodies on a glass coverslip. Protein complexes are imaged using TIRF microscopy and photobleaching 
step analysis of complexes reports on receptor stoichiometry (Jain et al., 2011). We restrict our analysis to 
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surface receptors by using N-terminally SNAP-tagged receptor constructs labeled with membrane-
impermeable fluorophores. Expression and labeling of constructs in HEK 293T cells with benzylguanine-
conjugated fluorophore BG-LD555 (Materials and methods) showed fluorescence labeling at the plasma 
membrane with minimal fluorescence inside the cell (Figure 1A). Receptors were immobilized using an 
HA-tag at the N-terminus of each construct that directly precedes the SNAP tag (Figure 1B). Consistent 
with previous work, SNAP-mGluR2-TMD molecules photobleached primarily in one-step (~55%) or two-
step (~40%) events with a small population of >3 steps (~4 %) (Figure 1C). This represents a population of 
~80% dimers when normalized to the obligatory dimerization of SNAP-mGluR2 (Figure 1D; see Materials 
and methods) (Gutzeit et al., 2019). 
Since mGluR TMDs do not form strict dimers, we asked if our preparation maintains the cellular 
composition of monomers and dimers or if TMDs exchange with one another during SiMPull experiments 
such that new dimers are formed. To test this, we either co-expressed HA-SNAP-mGluR2-TMD and CLIP-
mGluR2-TMD and labeled the same coverslip with both BG-LD655 (for SNAP) and BC-DY547 (for CLIP) 
or transfected and labeled separate coverslips with either constructs/fluorophore combination prior to 
mixing and co-lysis (Figure 1–figure supplement 1A-C). Following lysis, protein complexes were isolated 
via an anti-HA antibody. As expected, in the positive co-expression control HA-SNAP-mGluR2-TMD was 
able to co-precipitate many spots for CLIP-mGluR2-TMD (Figure 1—figure supplement 1D). In contrast, 
we observed background levels of spots for the test condition where separate populations of cells were 
mixed following labeling (Figure 1—figure supplement 1E, F). This suggests that there is no exchange 
between TMD dimers within detergent on the timescale of our experiments and indicates that our technique 
can be thought of as capturing a “snapshot” of TMD dimers and monomers in the cell membrane at the time 
of lysis. 
Consistent with prior work, SNAP-mGluR3-TMD molecules photobleached with a greater number 
of one-step (~70%) events, less two-step (~30%) events, and a similarly small population of >3 steps (~3%) 
(Figure 1C) compared to SNAP-mGluR2-TMD. Thus, unlike their full-length counterparts which both 
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show strict dimerization (Levitz et al., 2016), mGluR2-TMD and mGluR3-TMD show distinct dimerization 
propensities that are less than an obligate dimer but greater than a canonical class A GPCR, β2AR, which 
we used as a monomeric or weak dimerization control (Figure 1D). Importantly, SNAP-mGluR2-TMD and 
SNAP-mGluR3-TMD retained ~80% and ~50% dimerization, respectively, regardless of whether they were 
immobilized via their N or C-terminus (Figure 1—figure supplement 2). 
To confirm that the dimerization propensities observed in detergent-based single molecule subunit 
counting experiments reflect those occurring in the cell membrane, we measured ensemble FRET levels for 
the TMDs of both mGluR2 and mGluR3 at comparable expression levels in live cells. SNAP-mGluR2-
TMD or SNAP-mGluR3-TMD constructs were labeled with SNAP-reactive donor (BG-LD555) and 
acceptor (BG-LD655) fluorophores and fluorescence recovery of the donor was examined following 
acceptor bleaching with 640 nm illumination (Figure 1—figure supplement 3A). The percent change in 
donor fluorescence was greater for SNAP-mGluR2-TMD compared to SNAP-mGluR3-TMD, consistent 
with the interpretation that mGluR2 has a greater inter-TMD dimerization propensity compared to mGluR3 
(Figure 1—figure supplement 3B). As a control, SNAP-β2AR showed less donor recovery than both mGluR 
constructs (Figure 1—figure supplement 3B). Combined, these results indicate that our single molecule 
experiments are an accurate reflection of mGluR dimerization in the membrane.  
Next, we asked whether the variable propensity for TMD dimerization between mGluR2 and 3 has 
an effect in the full-length receptor context. To sensitize our constructs to effects at non-covalent interfaces, 
we mutated a cysteine within the LBD that produces an inter-subunit disulfide bond. Consistent with 
previous work (Levitz et al., 2016), mutation of the intersubunit disulfide bridge in mGluR2 (C121A) had 
a minimal effect on mGluR2 dimerization (Figure 1E). However, in stark contrast, the equivalent mutation 
in mGluR3, C127A, produced a substantial 2-fold reduction in dimerization (Figure 1E).  We hypothesized 
that differences in sensitivity to cysteine mutation are due to differences in the relative strength of inter-
TMD interaction and reasoned that if the TMD plays a role in mGluR dimerization, an mGluR2-C121A 
chimera with the mGluR3 TMD (“mGluR2-C121A-mGluR3TMD”) would reduce dimerization further. 
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Indeed, this construct showed normal expression (Figure 1—figure supplement 4) but reduced dimerization 
compared to mGluR2-C121A (Figure 1F). We next tested the reverse chimera to see if the mGluR2-TMD 
can rescue the weak dimerization of mGluR3-C127A. As hypothesized, “mGluR3-C127A-mGluR2TMD” 
showed un-altered expression (Figure 1—figure supplement 4) but increased dimerization compared to 
SNAP-mGluR3-C127A (Figure 1F). Together these results indicate that the TMD mediates differences in 
dimerization between full-length mGluR2 and mGluR3. Specifically, the greater dimer propensity between 
mGluR2 TMDs strengthens the full-length mGluR2 dimer while the lower affinity inter-TMD interactions 
in mGluR3 leads to less favorable dimer formation and therefore greater dimer dissociation in the mGluR3-
C127A background (Figure 1G). Notably, TMD chimeras were not able to fully swap the relative 
dimerization propensities between subtypes, suggesting that other differences outside of the TMD also 
contribute to differential assembly of mGluR2 and mGluR3. 
 
Residues in TM4 control the relative TMD dimerization propensities of mGluR2 and mGluR3 
Having demonstrated that the TMD plays a critical role in subtype-specific modes of mGluR 
dimerization, we wondered which specific regions of the TMD contribute to this effect. Together the 
existing literature suggests that inter-TMD interaction among class C GPCRs is multifaceted and diverse 
(see Introduction), motivating further analysis and careful comparison between receptor subtypes. We 
started by assessing sequence conservation across mGluR subtypes and between mGluR2 and mGluR3. 
Across all eight rat mGluRs, most TM helices show <50% sequence conservation and <30% sequence 
identity, while TM6 stands out as the most similar, with 96% conservation and 72% identity (Figure 2-
figure supplement 1A). Analysis of only the group II mGluRs reveals much greater sequence similarity, 
with all TMs having >80% conservation. Restricting analysis to outward-facing residues (defined by 
homology models based on the mGluR5 TMD crystal structure), which we expect to disproportionately 
contribute to TMD interface formation, we see marked differences (Figure 2-figure supplement 1A-C). 
Across all mGluRs, only TM6 remains highly similar, with 87.5% conservation and 87.5% identity. 
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Between the group II mGluRs, conservation remains high (>70%) for all TMs except for TM4 (33%) 
(Figure 2B). TM4 identity is also the lowest of the TMs at 0%. Given that the overall sequence identity 
between mGluR2 and mGluR3 is nearly 70%, it is reasonable to hypothesize that the increased 
heterogeneity of TM4 contributes to subtype-specific differences in TMD dimerization.  
To further address the TMD dimer interfaces of mGluR2 and mGluR3 we used extended CG MD 
simulations of pairs of receptors randomly placed relative to each other in a 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) lipid bilayer (Figure 2—figure supplement 2A) and analyzed them with 
Markov state models (MSMs) (Figure 2––figure supplement 2B). The results confirm a higher dimerization 
propensity for mGluR2-TMD compared to mGluR3-TMD (~40% and ~25% dimeric fractions, 
respectively), and a differential involvement of TMs in dimeric interfaces. We compiled all simulated dimer 
structures into macrostates consisting of a variety of symmetric and asymmetric configurations involving 
different combinations of TM helices (Figure 2—figure supplement 2B, C). Significant transition fluxes 
observed between the different dimeric macrostates (Figure 2––figure supplement 2B) indicate that direct 
interconversion between some of the identified dimeric configurations does not require reverting first to the 
monomeric state.   
To provide rough estimates of the effect of the extracellular domains on the stability of mGluR2-
TMD or mGluR3-TMD dimeric configurations identified in simulations, we carried out steered MD 
simulations of full-length CG models to representative dimeric configurations of the two receptors and 
calculated free-energy differences between them. While the identified symmetric (TM1,TM7)/(TM1,TM7) 
dimeric configuration of mGluR2-TMD was confirmed to be more stable than the asymmetric 
(TM1,TM7)/(TM4,TM3) and (TM1,TM7)/(TM5) mGluR2-TMD dimers (free-energy differences of -580 
± 18 kJ mol-1, -169 ± 18 kJ mol-1, respectively) in the presence of the LBD, other dimeric configurations 
such as the symmetric (TM4)/(TM4) dimer of mGluR2 (Figure 2—figure supplement 3A), showed higher 
compatibility with the full-length receptor than the (TM1,TM7)/(TM1,TM7) dimer and other highly 
populated macrostates (free energy differences of -1370 ± 18 kJ mol-1, -1950 ± 18 kJ mol-1, and -1540 ± 18 
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kJ mol-1 from the (TM1,TM7)/(TM1,TM7), (TM1,TM7)/(TM4,TM3), and (TM1,TM7)/(TM5), 
respectively). In contrast, the identified (TM4)/(TM4) dimer configuration of mGluR3-TMD (Figure 2—
figure supplement 3B), was estimated to be less stable than the identified largest mGluR3-TMD dimer 
macrostate in the presence of the LBD (free-energy difference of +630 ± 12 kJ mol-1 from the 
(TM2,TM7)/(TM3) interface).  
Together, examination of amino acid sequence conservation and MSM analysis of CG MD 
simulations point to TM4 as a potential mediator of the differential TMD dimerization of mGluR2 and 
mGluR3. Intriguingly, differences in TM4 between the group II mGluRs have been reported to contribute 
to the specific interaction of mGluR2, but not mGluR3, with the 5-HT2A serotonin receptor, a class A GPCR 
(Gonzalez-Maeso et al., 2008, Fribourg et al., 2011, Moreno et al., 2016, Delille et al., 2012). This 
interaction has been attributed to three outward-facing alanine residues (A677, A681, A685) at the cytosolic 
end of TM4 of mGluR2 (Figure 2A) that allow mGluR2, but not mGluR3, to interact with 5-HT2AR 
(Moreno et al., 2012). Importantly, these three alanine residues and the corresponding residues in mGluR3 
are conserved across species (Figure 2—figure supplement 1D) and are observed within many of the TM4-
containing dimer interfaces obtained by CG MD simulations (Figure 2—figure supplement 3). We thus 
wondered whether these alanine residues also play a role in mGluR homodimer formation. 
To test our hypothesis, we swapped A677, A681 and A685 in mGluR2 with the corresponding 
residues in mGluR3: S686, F690 and G694 (Figure 2A, B) and vice versa to create two mGluR-TMD 
mutants, “mGluR2-TMD-3xTM4” and “mGluR3-TMD-3xTM4”. Both mutants expressed similarly to 
wild-type receptors in HEK 293T cells and single molecules were isolated for SiMPull experiments (Figure 
2—figure supplement 4A, B). Strikingly, we found that dimerization propensity was determined by which 
3xTM4 residues were present in the construct (Figure 2C). For mGluR2-TMD-3xTM4, we observed a 
reduction in dimerization from ~80% for mGluR2-TMD to ~50%. Conversely, mGluR3-TMD-3xTM4 
increased dimerization from ~45% for mGluR3-TMD to ~70%. These data indicate that TM4 residues 
determine the relative dimerization propensity of group II mGluRs at the TMD level. Single amino acid 
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swap constructs in the SNAP-mGluR2-TMD background show that although each mutation individually 
alters dimerization, all three mutants combined in the 3xTM4 constructs are required for the greatest effect 
(Figure 2—figure supplement 4C, D). 
We also examined whether mutating other non-conserved outward-facing residues in TM4 
influences TMD dimerization. We swapped mGluR2 residues A695 and A696 with mGluR3 residues S703 
and V704 to make mGluR2-TMD-A695S/A696V. Notably, these positions were shown to cross-link in a 
prior study of mGluR2 (Xue et al., 2014). mGluR2-TMD-A695S/A696V exhibited indistinguishable 
dimerization compared to SNAP-mGluR2-TMD, suggesting that outward-facing residues at the 
extracellular end of TM4 do not influence the relative TMD dimerization propensities between mGluR2 
and mGluR3 (Figure 2—figure supplement 5A, B). We also tested differences between mGluR2 and 
mGluR3 in TM1 (F584, G587 in mGluR2 and I593, T596 in mGluR3) and TM5 (A726, G730, A733 in 
mGluR2 and S735, I739, T742 in mGluR3) by swapping non-conserved outward-facing residues and 
observed no effect in SiMPull (Figure 2—figure supplement 5C-E). Notably, among these residues, only 
one (F584 in mGluR2 and I593 in mGluR3) was found to participate in dimeric interfaces identified by 
simulation (specifically, the (TM1,TM7)/(TM1,TM7) interface; Figure 2-figure supplement 2).  
Importantly, these SiMPull and computational results do not rule out the possibility that the extracellular 
end of TM4, TM1 or TM5 contribute to TMD dimerization but they show that these regions are not 
mediators of the differences between mGluR2 and mGluR3. 
While isolated TMDs are very useful for studying TMD behavior directly, we asked if the identified 
TM4 residues are relevant within the context of full-length mGluRs. We first produced an mGluR2-C121A-
3xTM4 construct and examined dimerization compared to mGluR2-C121A and mGluR2-C121A-
mGluR3TMD. Consistent with isolated TMD data, we found that the effect of swapping the entire TMD 
was mimicked by only introducing the 3xTM4 mutant (Figure 2D). This effect was also observed with 
mGluR3-C127A-3xTM4 where the increase in dimerization matched what was observed for mGluR3-
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C127A-mGluR2TMD (Figure 2E). All mutants showed limited effects on receptor expression levels 
(Figure 2—figure supplement 6A-D).  
Together, these experiments and computations show that TM4 residues control the relative strength 
of interaction between TMDs, at least for mGluR2. Importantly, TMD chimeras or 3xTM4 swap mutations 
showed no clear effect on dimerization in full-length wild type backgrounds likely due to the maintenance 
of the disulfide bridge that stabilized LBD dimerization (Figure 2—figure supplement 6E). This indicates 
that cysteine mutation is needed to reveal the distinct inter-TMD interaction modes that exist within 
mGluR2 and mGluR3 dimers. 
 
TM4 residues control orthosteric and allosteric activation of group II mGluRs 
 Having observed a clear, but variable role for inter-TMD interfaces involving the cytosolic end of 
TM4, we next investigated how this region contributes to mGluR function. We turned to a calcium imaging 
assay in HEK 293T cells where a G-protein chimera (Conklin et al., 1993) allows Gi/o-coupled receptors, 
such as mGluR2 and mGluR3, to produce release of calcium from intracellular stores which can be 
quantified by measuring the fluorescence increase from a fluorescent calcium sensor such as GCaMP6f 
(Materials and methods). We started by measuring the glutamate response of wild type mGluR2 and 
mGluR3. As expected from previous studies (Levitz et al., 2016, Tora et al., 2018), mGluR3 showed a 
higher apparent glutamate affinity compared to mGluR2 (Figure 3—figure supplement 1A, B). Weakening 
the TM4 interface in mGluR2-3xTM4 produced a ~4-fold leftward shift compared to wild-type mGluR2 
(Figure 3A-C). Based on this result, we wondered whether mGluR3-3xTM4 would have reduced apparent 
glutamate affinity compared to mGluR3. Indeed, we observed a ~20-fold rightward shift for mGluR3-
3xTM4 compared to wild type mGluR3 (Figure 3D-F). To further understand the contribution of each 
residue, we also tested single mutants. Interestingly, mGluR2-A677S, -A681F, and -A685G did not show 
different glutamate EC50 values compared to wild type mGluR2 (Figure 3C; Figure 3—figure supplement 
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1C). Conversely, mGluR3-S686A, -F690A, and -G684A all exhibited significant rightward shifts compared 
to mGluR3, though no single mutant had as reduced apparent affinity as mGluR3-3xTM4 (Figure 3F; 
Figure 3—figure supplement 1D). Together, these measurements show that inter-TM4 interactions 
influence orthosteric activation of group II mGluRs.   
 We also tested glutamate responses of the TM1 (F584I/G587T), TM4 (A695S/A696V) and TM5 
(A726S/G730I/A733T) mutants, which showed no change compared to wild-type in dimerization 
experiments (Figure 2—figure supplement 5). Consistent with their lack of effect on dimerization, both 
mGluR2-F584I/G587T and mGluR2-A726S/G730I/A733T showed identical concentration response 
curves compared to wild type mGluR2 (Figure 3C; Figure 3—figure supplement 1E). 
 Next, we wondered whether the 3xTM4 residues also influence allosteric activation. Our work and 
others’ have demonstrated that PAMs can function as direct agonists of mGluR2 (Gutzeit et al., 2019, El 
Moustaine et al., 2012, Goudet et al., 2004, O'Brien et al., 2018). We tested the mGluR2 PAM LY487379 
(LY48) (Johnson et al., 2003) with mGluR2 and mGluR2-3xTM4. Like the glutamate response, we 
observed a small leftward shift in EC50 for mGluR2-3xTM4 compared to wild type mGluR2 (Figure 3G, 
Figure 3—figure supplement 1F). We also observed that the mGluR2-3xTM4 LY48 PAM response showed 
greater maximal efficacy, with saturating (100 µM) LY48 giving ~20% greater amplitude compared to wild 
type mGluR2. This finding shows that 3xTM4 residues also influence allosteric activation. 
Given the clear effects of TM4 perturbations on group II mGluR function, we asked what the effects 
of harsher alteration of this interface would be. Critically, we wondered if further disruption of the TMD 
interface would enhance activation or impair it, providing a clue into whether a TM4-containing interface 
is a necessary intermediate along the activation pathway or merely associated with an inactive state. We 
introduced bulky, hydrophobic tryptophan residues into outward facing residues of TM4 to disrupt inter-
subunit interaction. We first produced mGluR2-3xTM4_W (A677W, A681W, A685W) in the isolated 
TMD background and observed reduced dimerization compared to both mGluR2-TMD and mGluR2-
3xTM4 (Figure 3—figure supplement 1G). In contrast to what was observed with mGluR2-3xTM4, full-
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length mGluR2-3xTM4_W showed a small right-shift in the functional calcium imaging concentration 
response curve (Figure 3H), suggesting that harsh perturbation to the lipid-targeting face of TM4 impairs 
activation. Consistent with this, mGluR3-3xTMD_W (S686W/F690W/G684W) showed similarly weak 
dimerization compared to wild type mGluR3-TMD (Figure 3—figure supplement 1G) and a pronounced 
right-shift compared to wild type mGluR3 in the functional calcium imaging assay (Figure 3I). Together 
these results confirm the importance of TM4 in group II mGluR TMD dimerization and suggests that, 
despite the weaker TM4-mediated dimerization of mGluR3, outward-facing residues in TM4 are still 
important for inter-subunit rearrangement along the activation pathway for both receptor subtypes.  
 
SNAP- and Halo-based FRET sensors enable analysis of the effects of TM4 interface perturbation on 
conformational dynamics of full-length mGluRs 
 Having established the role of TM4 residues in influencing dimerization and both orthosteric and 
allosteric activation, we next wondered how they influence mGluR conformational dynamics using 
fluorescence resonance energy transfer (FRET). We first examined whether TM4 residues influence inter-
LBD dynamics using a well-established assay where a decrease in FRET between N-terminal SNAP-tags 
is correlated with activation-associated inter-LBD reorientation (Doumazane et al., 2013, Olofsson et al., 
2014, Vafabakhsh et al., 2015). HEK 293T cells were transfected with SNAP-tagged mGluR constructs 
and after labeling with SNAP-reactive donor (BG-LD555) and acceptor (BG-LD655) fluorophores 
(Materials and methods), the donor fluorophore was excited with a 561 nm laser while donor and acceptor 
channels were imaged simultaneously with a dual camera imaging system as described previously (Gutzeit 
et al., 2019). 3xTM4 mutants produced inter-LBD FRET responses that were indistinguishable from their 
wild-type counterparts with identical glutamate concentration-response curves (Figure 4—figure 
supplement 1). As previously shown, mGluR3 but not mGluR2 showed a clear basal FRET response to the 
competitive antagonist LY341495 in the absence of glutamate, consistent with constitutive inter-LBD 
dynamics that drive basal activity (Vafabakhsh et al., 2015, Levitz et al., 2016). mGluR3-3xTM4 
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maintained a basal response to LY34 that was indistinguishable from WT, while both mGluR2 and 
mGluR2-3xTM4 showed no basal response to LY34 (Figure 4—figure supplement 1). Together these data 
show that 3xTM4 mutants undergo normal LBD motions, suggesting that their functional effects are 
mediated downstream at the TMDs themselves. Furthermore, this underscores the large effects of the 
3xTM4 mutations on receptor activation, given that despite normal glutamate sensitivity at the LBDs 
apparent glutamate affinities were shifted by up to nearly 20-fold in the case of mGluR3 (Figure 3).  
We next sought to directly probe dynamics at the TMD by developing new FRET sensors based on 
ours and others’ previous studies of mGluR1 where insertion of fluorescent proteins (i.e. CFP/YFP) into 
intracellular loops or C-termini have yielded sensors of activation-associated conformational changes that 
are suitable for live cell studies (Hlavackova et al., 2012, Marcaggi et al., 2009, Grushevskyi et al., 2019, 
Tateyama et al., 2004, Tateyama and Kubo, 2006). We re-engineered this approach to incorporate HaloTags 
(Los et al., 2008) which enable the use of organic fluorophores, such as the family of rhodamine-based 
Janelia Fluor (“JF”) dyes (Grimm et al., 2016, Grimm et al., 2020), which show enhanced brightness and 
stability compared to fluorescent proteins. We produced constructs where a HaloTag is inserted into the 
second intracellular loop of mGluR2 or mGluR3 to monitor proximity between TMDs (Figure 4A). 
Following expression, these constructs were labeled with HaloTag donor (JF549) and acceptor (JF646) dyes 
at a 1:3 ratio where optimal results were observed (Figure 4—figure supplement 2A). Consistent with prior 
fluorescent protein-based constructs for mGluR1, glutamate application resulted in a FRET increase for 
both the mGluR2 and mGluR3 sensors (Figure 4B; Figure 4—figure supplement 2B, C). Importantly, no 
FRET responses were observed when constructs were labeled with only donor or only acceptor 
fluorophores (Figure 4-figure supplement 2D, E). FRET responses were reversible upon drug washout and 
concentration-dependent (Figure 4—figure supplement 3A, B). Concentration response curves for wild-
type constructs showed the expected higher apparent affinity for mGluR3 compared to mGluR2 (Figure 
4C).  
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We further characterized the sensitivity of the FRET sensors to different types of compounds. As 
expected, glutamate responses were fully blocked by the competitive antagonist LY341495 (Figure 4—
figure supplement 3C, D) at the same concentration (5 µM) used for block of functional responses (Figure 
4—figure supplement 3E, F). We next asked if glutamate-induced FRET increases are blocked by TMD-
targeting mGluR NAMs. We focused on the non-specific group II mGluR NAM MNI 137, which (10 µM) 
was only able to produce a weak, partial block of glutamate-induced FRET responses (~30-50%) (Figure 
4D, E; Figure 4—figure supplement 3G) at the same saturating concentration (10 µM) where full block of 
functional responses was observed (Figure 4E; Figure 4—figure supplement 3H, I). Further raising the MNI 
137 concentration to 50 µM (IC50 ~10 nM (Hemstapat et al., 2007)) did not increase the extent of block of 
glutamate-induced mGluR3 FRET responses (42.9 ± 7.4 %,  n=8 for 10 µM; 44.9 ± 8.3 %, n=3 for 50 µM).  
These results indicate that these FRET sensors partially report on conformational changes that are 
insensitive to NAMs. In addition, we tested a saturating concentration of the mGluR2 PAM LY48 and, in 
contrast to its robust functional activation properties (Figure 3G), observed weak FRET increases that were 
~20-30% of the amplitude of the response to saturating glutamate (Figure 4F). This indicates that the inter-
TMD motions detected by the FRET sensor are partially insensitive to allosteric modulators.  
Next, we asked if the inter-TMD FRET sensors are sensitive to perturbation to TM4. We found that 
mGluR2-3xTM4 exhibited a clear leftward-shift compared to mGluR2, while mGluR3-3xTM4 exhibited a 
rightward-shift compared to mGluR3 (Figure 4G-I), supporting a role for TM4 in controlling intersubunit 
motions. In addition, mGluR3-3xTM4 exhibited a reduced basal FRET response to LY341495 compared 
to wild type mGluR3 (Figure 4J, K; Figure 4—figure supplement 3K, L), suggesting that the strengthened 
TM4 interface is capable of decreasing the basal activity of the receptor.  We tested basal receptor activity 
using a previously described (Gutzeit et al., 2019) GIRK-channel based patch clamp assay and, indeed, 
observed substantially reduced basal activity for mGluR3-3xTM4 compared to wild type mGluR3 (Figure 
4L, M). Interestingly the basal FRET response was larger for LY341495 than MNI 137, despite comparable 
responses to both antagonists in the patch clamp assay (Figure 4—figure supplement 3J-L), further 
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supporting the partial sensitivity of the FRET sensor to allosteric compounds. Together these results 
indicate that orthosteric and allosteric compounds differentially control inter-TMD conformational 
dynamics and that these dynamics are tuned by a TM4-containing dimer interface.  
 
Testing an inter-TMD rearrangement model of mGluR activation 
 Previous biochemical and structural studies have strongly argued that TMDs undergo reorientation 
to a TM6 interface upon activation (Xue et al., 2014, Koehl et al., 2019). Notably, TM6 is highly conserved 
across mGluR subtypes compared to other transmembrane helices and is 100% identical between mGluR2 
and mGluR3 (Figure 2—figure supplement 1). This supports a model where divergent inter-TMD 
interaction modes across mGluR subtypes in inactive states converge on a common active-state interface. 
To test this model of mGluR activation, we introduced mutations at the TM6 interface based on the full-
length mGluR5 agonist- and PAM-bound cryo-EM structure where a single point of contact exists between 
TMDs centered on conserved isoleucine 791 (I779 in mGluR2 and I788 in mGluR3) in TM6 (Koehl et al., 
2019) (Figure 5A). We first tested alanine (I779A) and tryptophan (I779W) mutants in the isolated 
mGluR2-TMD to determine if either mutation altered dimerization in SiMPull experiments. Interestingly, 
both mutants showed ~20% reduced dimerization compared to the wild type mGluR2-TMD (Figure 5—
figure supplement 1A-C), suggesting that both TM4- and TM6-containing interfaces contribute to the dimer 
population in this assay. Mutation to a nearby conserved proline (P778) in the TM6 interface also decreased 
TMD dimerization (Figure 5—figure supplement 1C) and mutation to the same conserved TM6 residue in 
mGluR3, I788A, produced a similar decrease in TMD dimerization (Figure 5B).  
To determine whether functional differences exist between the mutants, we performed calcium 
imaging experiments with mutations in the full-length mGluR2 background. mGluR2-I779W, -I779A, and 
-P778A-I779A all showed right-shifted concentration response curves compared to mGluR2 while 
mGluR2-P778A was not significantly different but did show a modest left-shift (Figure 5C, E; Figure 5—
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figure supplement 1D, E). Similar to mGluR2, mGluR3-I788A showed a ~18-fold rightward shift in 
glutamate response compared to wild-type (Figure 5D, E; Figure 5—figure supplement 1F), suggesting that 
this residue indeed plays an important conserved role in group II mGluR activation.  
Having confirmed the importance of inter-TM6 interactions to orthosteric activation, we asked if 
this interface also influences allosteric drug activation. It remains unclear how similar the orthosteric and 
allosteric activation pathways are given that these ligands bind at very distant sites and are able to activate 
mGluRs independently of each other. Notably, mGluR2 and mGluR4 PAMs can activate full-length 
receptors even in the presence of orthosteric antagonists suggesting that LBD-driven re-arrangement can 
be bypassed by TMD-targeting compounds (Gutzeit et al., 2019, Rovira et al., 2015). We tested the response 
of mGluR2-I779A to LY48 and found a ~12-fold rightward shift and a ~30% reduction in maximal PAM 
efficacy compared to saturating glutamate (Figure 5F). Together, these results clearly indicate that TM6 
interactions also play a role in allosteric activation.  
Next, we asked how weakening the TM6 interface would alter the conformational dynamics 
detected by our TMD FRET sensors. We introduced the I779A mutation into the mGluR2 inter-subunit 
FRET sensor and observed a modest right shift in the concentration response curve (Figure 5G; Figure 5—
figure supplement 1G). While the functional assay revealed an 18-fold rightward shift for I779A, the change 
in EC50 was only ~2-fold, consistent with this sensor primarily sensing steps in the activation process that 
occur prior to TM6 interface formation or conformational changes stabilized by the TM6 interface. A 
similar, small right-shift was observed with the mGluR3 inter-TMD FRET sensor (Figure 5H; Figure 5—
figure supplement 1H). Combined, these results underscore the importance of the TM6 interface in the 
conformational changes that drive group II mGluR activation.  
 Having determined that both the cytosolic end of TM4 and the extracellular end of TM6 shape the 
mGluR activation process, we next sought to further clarify the specific role of each region in mediating 
TMD dimerization with the hypothesis that a TM4 to TM6 interface switch occurs during both orthosteric 
and allosteric activation. This interface is both based on our data and aforementioned previous cross-linking 
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and structural studies (Koehl et al., 2019, Xue et al., 2014). We decided to conduct SiMPull experiments 
on wild-type and mutant receptors in the presence of ligands to investigate effects on receptor dimerization 
strength.  
We previously found that allosteric drugs did not alter the dimerization of the mGluR2 TMD 
(Gutzeit et al., 2019). However, we anticipated that weakening either the TM4 or TM6 interface (Figure 
6A) would sensitize the mGluR2-TMD to shifts in dimerization strength produced by stabilizing distinct 
states. Indeed, while wild type mGluR2-TMD showed no sensitivity to PAM or NAM treatment, mGluR2-
TMD-3xTM4 showed a clear increase in dimerization following treatment with a PAM (TASP) while 
mGluR2-TMD-I779A showed a clear increase following treatment with a NAM (MNI 137) (Figure 6B; 
Figure 6—figure supplement 6A-C). This result is consistent with a model where PAM treatment shifts the 
dimer toward a TM6 interface enabling rescue of weak TM4-mediated dimerization for 3xTM4 whereas 
NAM treatment shifts the dimer toward a TM4 interface to rescue the weak TM6-mediated dimerization of 
I779A. Supporting this, simultaneously weakening both interfaces with combination of 3xTM4 and I779A 
mutations prevented any PAM- or NAM-induced dimerization shifts (Figure 6A, B; Figure 6—figure 
supplement 1D).  
 We next conducted the same experiments in the mGluR2-C121A background (Figure 6C) to assess 
whether this model also described dimer rearrangement for full-length receptors. Similar to the wild-type 
mGluR2-TMD, mGluR2-C121A dimerization was unchanged by ligands (Figure 6D; Figure 6—figure 
supplement 1E). However, mGluR2-C121A-3xTM4 showed a clear increase in dimerization following 
treatment with a PAM or glutamate (Figure 6D; Figure 6—figure supplement 1F) and mGluR2-C121A-
I779A showed increased dimerization following treatment with a NAM (Figure 6D; Figure 6—figure 
supplement 1G). Lastly, mGluR2-C121A-3xTM4-I779A retained reduced dimerization (~45%) with and 
without all ligands (Figure 6D; Figure 6—figure supplement 1H). Together, these findings support a model 
of mGluR TMD activation in which TM4 supports the inactive mGluR TMD interface and reorientation to 
a TM6 interface is required for activation. 
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 Next, we wondered whether the same inactive and active interfaces could be observed for mGluR3. 
Since mGluR3-C127A already shows reduced dimerization compared to mGluR3 (Figure 6E), we 
anticipated that the addition of ligands might alter dimerization without further mutation to the TMD. 
Indeed, addition of LY34 decreased dimerization while addition of glutamate increased dimerization 
(Figure 6F; Figure 6—figure supplement 1I). Strengthening the TM4 interface in mGluR3-C127A-3xTM4 
prevented the ligand-induced effects on dimerization strength (Figure 6F; Figure 6—figure supplement 1J), 
likely due to a relative balance in dimerization strength between TM4 and TM6 in this construct as is seen 
with mGluR2. Finally, we tested mGluR3-C127A-I788A and observed a small increase in dimerization 
following the addition of LY34 and no difference in the presence of glutamate (Figure 6F; Figure 6—figure 
supplement 1K). Overall, these results establish the combination of drug treatment with single molecule 
pulldown as a means to assess ligand-induced membrane protein assembly and support a general model of 
ligand-regulated shift between TM4 and TM6-containing dimer interfaces (Figure 6G).  
 
Inter-TMD interactions fine-tune the assembly of mGluR2/3 heterodimers 
 An increasingly appreciated aspect of mGluR molecular diversity is the formation of heterodimers 
which have been shown to have unique pharmacological and functional properties (Levitz et al., 2016, 
Habrian et al., 2019, Yin et al., 2014, Delgado et al., 2017, Liu et al., 2017, Sevastyanova and 
Kammermeier, 2014, Werthmann et al., 2020). We recently showed that extensive co-expression of mGluR 
subtypes occurs throughout the brain and that a complex set of preferences determines the relative 
propensities for heterodimerization of different mGluR pairs (Lee et al., 2020). Among the most preferred 
pairs are mGluR2 and mGluR3 which readily form heterodimers following heterologous expression and 
can be co-immunoprecipitated from the frontal cortex. Given our finding that mGluR2 and mGluR3 
homodimers have distinct inter-TMD interaction properties, we asked how this would manifest in the 
mGluR2/3 heterodimer: Are mGluR2 and mGluR3 TMDs able to interact? Does the TMD-TMD interface 
resemble mGluR2 or mGluR3 homodimers? 
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 We first performed 2-color SiMPull experiments to determine if the isolated HA-SNAP-mGluR2-
TMD construct can pull down CLIP-mGluR2-TMD or CLIP-mGluR3-TMD (Figure 7A). We labeled HA-
SNAP-mGluR2-TMD with BG-LD655 (red) and either CLIP construct with BC-DY547 (green) and 
calibrated surface expression to be comparable between conditions (Figure 7—figure supplement 1A, B), 
before isolating receptor complexes using the anti-HA antibody (Figure 7A) as was done for previous 1-
color experiments. While SNAP-mGluR2-TMD was able to pull-down both constructs, a higher level was 
observed for CLIP-mGluR2-TMD (Figure 7B), suggesting that TMD heterodimers can form but the inter-
TMD interface of mGluR2 homodimers is more stable than that of mGluR2/3 heterodimers. We performed 
the reverse experiment with HA-SNAP-mGluR3-TMD (Figure 7C) and found higher levels of pulldown 
for CLIP-mGluR2-TMD compared to CLIP-mGluR3-TMD (Figure 7D), suggesting that the inter-TMD 
assembly of mGluR3 homodimers is less stable than that of mGluR2/3 heterodimers.  
 We next investigated inter-TMD interaction of mGluR2/3 homodimers in the full-length context. 
Consistent with previous work (Lee et al., 2020), at comparable levels of surface-expression, full-length 
mGluR2 preferentially assembles with mGluR3 (Figure 7E,F; Figure 7—figure supplement 2A,B). 
However, mutating the intersubunit disulfide-forming cysteine (C121A in mGluR2; C127A in mGluR3) 
resulted in a dramatic swap of the dimerization preference. HA-SNAP-mGluR2-C121A pulled down CLIP-
mGluR2-C121A at nearly wild-type levels, consistent with the minor effect of this mutation on mGluR2 
homodimerization (Figure 1D) but pulled down a much lower level of CLIP-mGluR3-C127A (Figure 7E, 
F). Consistent with isolated TMD results, SNAP-mGluR3-C127A also showed a weak preference for CLIP-
mGluR2-C121A over CLIP-mGluR3-C127A (Figure 7G). To test whether inter-TM4 interactions 
contribute to the distinct assembly properties of mGluR2/3 heterodimers, we introduced the 3xTM4 
mutation into CLIP-mGluR3-C127A and observed enhanced pulldown via SNAP-mGluR2-C121A (Figure 
7F). While this was unable to rescue mGluR2/3 heterodimerization back to the level of wild-type receptors, 
this result clearly indicates that this stretch of TM4 is a determinant of the assembly of mGluR2/3 
heterodimers. Similarly, introducing the 3xTM4 mutation into CLIP-mGluR2-C121A decreased the 
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efficiency of pulldown via SNAP-mGluR3-C127A (Figure 7G). Together these data indicate that 
mGluR2/3 TMD dimers show an intermediate affinity compared to their parent homodimers (Figure 7H), 




Despite advancements in our understanding of dimeric family C GPCR assembly and activation at 
the level of the extracellular domains (Ellaithy et al., 2020), it has remained less clear how TMDs interact 
and rearrange in this process. Our findings provide new insight into the molecular basis of mGluR TMD 
association and argue for a perspective that takes into account an ensemble of inter-TMD dimerization 
states that are dynamically populated with distinct occupancies across subtypes.  
Our finding that swapping TMDs between mGluR2 and mGluR3 swaps dimerization strength, 
demonstrates that subtype-specific interactions between TMDs affect full-length mGluR dimer assembly. 
Furthermore, our discovery that three membrane-facing residues at the cytoplasmic end of TM4 confer 
differences between mGluR2 and mGluR3 builds on previous reports of TM4 as a putative mGluR2 TMD 
interface based on cross-linking (Xue et al., 2014, Koehl et al., 2019, Gonzalez-Maeso et al., 2008), while 
adding a critical new perspective that dimer assembly can vary dramatically within a receptor subfamily 
and even between two closely related receptors with >70% sequence identity. The conserved triple alanine 
motif in TM4 of mGluR2 and the corresponding differences in mGluR3 raise questions about the 
mechanism by which these residues contribute to TMD dimerization strength. Alanine is a small, nonpolar 
amino acid which has been demonstrated to display a preference to be buried when in an alpha-helical 
transmembrane helix (Ulmschneider and Sansom, 2001) and can contribute to tight helix-helix packing due 
to its short side chain (Senes et al., 2000, Eilers et al., 2000). For example, in potassium channels, alanine 
has the most frequent occurrence at helix interfaces (Javadpour et al., 1999). Conversely, the mGluR3 TM4-
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containing dimer region corresponding to the conserved triple alanine motif in mGluR2 TM4 includes 
serine, phenylalanine, and glycine residues. The hydrophobic and bulky nature of phenylalanine makes this 
residue less favorable for close helix-helix packing in membrane proteins (Eilers et al., 2000). Serine has 
been found to contribute to transmembrane packing, although less so than alanine (Eilers et al., 2000) and 
its polarity and position enable cytosol-facing orientations as seen in our mGluR3 homology model (Figure 
2A). Glycine, the smallest amino acid due to its lack of a side chain, often occurs at helix-helix interfaces 
in transmembrane regions (Senes et al., 2000). However, biochemical experiments in a model 
transmembrane helix and molecular dynamics simulations have argued that glycine is helix destabilizing in 
membrane proteins as it can induce local flexibility (Dong et al., 2012, Högel et al., 2018). Such helix 
destabilization may impair formation of stable intersubunit interfaces for mGluR3.  
 Our data on mGluR2/3 heterodimer assembly (Figure 7) confirms the dominant role of inter-LBD 
interfaces in determining relative dimer propensities (Levitz et al., 2016, Lee et al., 2020). However, the 
dramatic effect of disruption of inter-subunit disulfide bonds reveals an unexpected critical role for this 
covalent linkage in determining the enhanced assembly of mGluR2/3 heterodimers compared to mGluR2 
homodimers. TM4 interfaces are a clear contributor to the assembly of mGluR2/3 heterodimers with 
stronger interaction observed for heterodimers compared to mGluR3 homodimers and weaker interaction 
compared to mGluR2 homodimers. This likely shapes the activation properties of this complex which we 
have previously shown to have intermediate glutamate affinity, basal activity and cooperativity compared 
to parent homodimers (Levitz et al., 2016). The considerable variability observed within TM4 and other 
helices across group I and group III mGluRs (Figure 2—figure supplement 1) suggests that further 
complexity likely exists in TMD dimerization beyond the group II subtypes. We’ve previously shown that 
mGluR2 TMD dimerization is stronger than that observed for both mGluR1 and mGluR5 (Gutzeit et al., 
2019) which is in line with the lack of an inter-TMD interface in the inactive, antagonist-bound mGluR5 
cryo-EM structure (Koehl et al., 2019). Consistent with this, only mGluR2 shows the triple alanine motif 
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at the bottom half of TM4 suggesting that while TM4 interfaces may contribute to dimerization across all 
subtypes, mGluR2 maintains uniquely strong constitutive interactions between TMDs.  
Most importantly, our study provides new insight into the role of inter-TMD interaction in the 
activation of mGluRs. While strengthening the TM4 interface hinders receptor activation and inter-TMD 
re-arrangement, weakening the TM4 interface has more complex effects that can either enhance activation, 
in the case of 3xTM4 on mGluR2, or impair activation, in the case of harsher tryptophan mutants (Figure 
3, 4). Based on these results we anticipate that outward-facing residues in TM4 can both stabilize inactive 
states, as seen in wild-type mGluR2 and a previous study where TM4/TM5 crosslinking impaired receptor 
activation (Xue et al., 2014), but can also contribute to the receptor activation pathway. Such observations 
are in-line with the MSM analysis of our CG MD simulations, which reveals many distinct modes of TM4-
based dimerization, including those that engage helices other than TM4, and especially TM1. It’s possible 
that distinct modes are associated with inhibited inactive states while others are likely to be intermediates 
along an activation pathway that converges on TM6 interfaces. Notably, the MSM analysis of mGluR2 
reveals a direct reactive flux between the identified macrostate of TM4-containing dimers and the 
macrostate containing TM6-containing helices, whereas equivalent macrostates identified for mGluR3 are 
only indirectly connected.  Most clearly, our ligand coupled SiMPull analysis (Figure 6), strongly supports 
a TM4 to TM6 re-arrangement along the activation pathway with both orthosteric and allosteric agonists 
favoring a TM6 interface while antagonists stabilize a TM4 interface. It’s notable that TM6-containing 
interfaces are formed with much lower probability with respect to others in our inactive-state MD 
simulations, suggesting that an active TMD and/or active LBDs are required to engage this interface. 
Finally, TM1 interfaces are prominent in our MD simulations, with TM1-containing dimers being among 
the most probable configurations alongside TM4-containing dimers. While our computations suggest that 
TM1 is involved in a variety of kinetically inter-changeable asymmetric dimers, TM1 interfaces could also 
be relevant for higher order oligomers, as proposed for mGluR2 in neurons (Møller et al., 2018). 
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Taking into consideration the results of this study along with existing literature, we have illustrated 
a working 4-state model of mGluR activation at the level of the TMDs (Figure 8A). While our MSM 
analysis suggests that many microstates likely contribute to the activation pathway, this simplified model 
proposes that TMDs transition between a monomeric assembly, TM4-containing dimer assemblies and a 
TM6-containing active dimer interface that transitions to an active TMD conformation stabilized by 
agonists, PAMs and G proteins. Notably, the highly probable TM4-containing dimer macrostates and the 
least probable TM6-containing macrostates of inactive mGluR2 and mGluR3 appear to be connected both 
directly and indirectly by reactive fluxes. In the first step of our proposed 4-state model of mGluR 
activation, monomeric TMDs are able to associate to form dimers via TM4-containing interfaces. In the 
case of mGluR2, such TM4-containing interfaces are considerably more stable than in mGluR3 with 
mGluR2/3 showing an intermediate level (Figure 8B), based on SiMPull measurements (Figure 1, 2) and 
the larger FRET change observed with the mGluR3 inter-TMD FRET sensor (Figure 4). Following TM4 
dimer formation, a dimer reorientation step enables the formation of a TM6 interface. We hypothesize that 
the intersubunit FRET sensors are likely able to sense a mix of step 1 and step 2. Based on the fast transitions 
previously observed with similar inter-TMD FRET sensors on the same ~1-10 ms timescale as inter-LBD 
rearrangement (Grushevskyi et al., 2019, Hlavackova et al., 2012, Olofsson et al., 2014), the first transition 
is likely driven by the agonist-induced relaxed to active LBD transition where the intermediate cysteine-
rich domains (CRDs) come into closer proximity (Koehl et al., 2019, Huang et al., 2011, Liauw et al., 2021). 
Given the partial sensitivity of the intersubunit FRET sensors to NAMs and PAMs, we propose that step 1 
is largely insensitive to allosteric drugs which primarily control the reorientation between TM4 and TM6 
interfaces. This is in line with our previous mGluR2 inter-TMD FRET measurements with isolated domains 
where changes in FRET but not monomer: dimer equilibrium were observed with PAMs and NAMs 
(Gutzeit et al., 2019). One possibility not explicitly acknowledged in our model is that there may be 
transitions directly from a monomeric TMD state to the active TM6 interface. However, the impaired 
activation observed with mGluR3-3xTM4_W suggests that some form of TM4 interaction is part of the 
activation pathway. Along these lines, the proposed metastability of TM4 interfaces may explain why they 
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have not yet been observed in static structures solved by crystallography or cryo-EM, although our steering 
simulations suggest that symmetric TM4-containing dimers should be relatively stable in the full-length 
mGluR2. However, the clear effect of perturbing this interface and the subtype differences suggest that it 
may be a potential target for specific and potent drugs. Intriguingly, inter-TMD PAM and NAM binding 
has recently been observed in cryo-EM structures of GABABRs (Mao et al., 2020, Shaye et al., 2020), 
indicating that TMD interfaces may be druggable sites across family C GPCRs. 
Our model posits that TMD dimer rearrangement precedes the intra-TMD conformational changes 
that drive G protein activation. This is consistent with our previous studies of mGluR1 where intersubunit 
FRET sensors show faster (1 ms) FRET changes compared to intrasubunit sensors (~10-20 ms) 
(Grushevskyi et al., 2019, Hlavackova et al., 2012). Following dimer rearrangement, an intra-TMD 
conformational step is likely required to enable receptor activation. Furthermore, we anticipate that the 
transition between inactive and active TMD conformations is likely stabilized by G proteins (Figure 8C), 
as has been reported for family A GPCRs (Nygaard et al., 2013, Manglik et al., 2015, Rasmussen et al., 
2011, Weis and Kobilka, 2018). The lack of such stabilization by G proteins likely explains why the intra-
subunit TMD conformation in agonist, PAM and allosteric nanobody-bound mGluR5 cryo-EM structure is 
very similar to the TMD conformation seen in the apo state (Koehl et al., 2019).  
It’s important to note that alternative activation pathways may be reasonably proposed. For 
example, given that PAMs can activate isolated monomeric mGluR2 (El Moustaine et al., 2012) and a 
previous study showed only modest inhibition of PAM responses in a TM4/TM5-crosslinked mGluR2 (Xue 
et al., 2014), it’s possible that allosteric activation can proceed without inter-TMD interaction. However, 
the clear effects of TM4 and TM6 interface mutations on PAM responses in our study (Figure 3, Figure 6), 
indicate that this is likely not the typical pathway taken. In addition, it is difficult to distinguish between a 
“rolling” dimer interface model where many dimeric microstates exist en route to a TM6 interface versus 
a dynamic association/re-association model where TM4 interfaces are fully broken prior to reformation of 
a TM6-containing active interface. However, both our MSM analysis of the MD simulations and prior 
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crosslinking studies suggest that macrostates of TM4- and TM6-containing dimers are kinetically connected 
which favors the former interpretation. Overall, this model is meant to provide a framework for thinking 
about the possible routes of activation but higher resolution structural and, especially, computational and 
spectroscopic measurements will be needed to decipher the complex activation dynamics of different homo- 
and hetero-dimeric mGluR subtypes. Of critical importance is understanding how the molecular motions 
of the LBDs and CRDs on the millisecond and sub-millisecond timescales are transmitted to the many 
micro- and macro-states of the TMDs.  
What is the biological relevance of the modulatory effects of TMD dimerization differences 
between subtypes? The variable strength of the TM4 interface likely contributes to the tuning the mGluR 
activation dynamics to the synaptic roles of each particular subtype. The ~3-20-fold shifts in apparent 
glutamate affinity observed when swapping residues between mGluR2 and mGluR3, while subtle, are 
highly relevant in the context of the spatiotemporally complex dynamics of synaptic and extra-synaptic 
glutamate (Reiner and Levitz, 2018). Our data also suggest that in addition to controlling apparent glutamate 
sensitivity, relative inter-TMD dimerization strength tunes the basal activity, and likely also shapes the 
signaling kinetics of different mGluRs. Outside of the mGluR homo- and hetero-dimer context, the 
proposed inactive TM4 interface is intriguing to consider in the context of the mGluR2-5HT2AR interaction, 
which was reported to require the same three alanine residues for heterocomplex formation (Moreno et al., 
2012, Moreno et al., 2016). Our working model suggests that formation of this heterocomplex would either 
require activation of mGluR2 to induce TMD reorientation away from a TM4 mGluR interface or 
stabilization of a state where TMD dimers are unable to interact. In line with this hypothesis, previous work 
found that co-expression of mGluR2 and 5-HT2AR increased glutamate-elicited Gi/o activation (Fribourg et 
al., 2011). More work will be required to fully understand this unique inter-family interaction and if such 
inter-TMD interactions occur beyond the prototypical mGluR2-5HT2AR complex.  
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Materials and methods: 
Cell culture, molecular cloning and gene expression 
HEK 293T cells were purchased from ATCC and validated by DNA profiling (Bio-Synthesis, Inc). They 
tested negative for mycoplasma using a commercial kit. The cells were cultured in DMEM with 5% FBS 
on poly-L-lysine-coated glass coverslips. Lipofectamine 2000 (Thermo Fisher) was used for transfection 
of DNA plasmids. For single-molecule pulldown (SiMPull) experiments, cells were transfected with 0.7 
µg DNA of HA- and SNAP-tagged receptor constructs. For calcium imaging experiments, cells were 
transfected with the mGluR of interest, a Gαqi3 chimera (Conklin et al., 1993) and GCaMP6f, in a 7:5:3 
ratio with 0.7 µg of receptor. For FRET experiments, cells were transfected with either 0.7 µg SNAP-tagged 
constructs or 0.7 µg HaloTag constructs. For inter-TMD FRET experiments, HaloTags were inserted in 
ICL2 at an identical position in both mGluR2 and mGluR3 (directly following I669 in mGluR3 and I660 
in mGluR2). An alanine-serine linker precedes the HaloTag and a leucine-glutamatic acid linker follows it. 
SNAP-mGluR-TMD clones were made as described in (Gutzeit et al., 2019). All mutations were made 
using standard PCR-based techniques. TMD swap chimeras were made using Gibson assembly (Gibson et 
al., 2009). For mGluR3-mGluR2TMD, Q558 to P821 of mGluR2 was inserted into mGluR3 between P556 
and Q831. For mGluR2-mGluR3TMD, E567 to P830 of mGluR3 was inserted into mGluR2 between P835 
and Q800.  
Single-molecule pulldown and subunit counting 
Single-molecule pulldown (SiMPull) was performed as previously described (Levitz et al., 2016). Briefly, 
flow chambers were prepared with mPEG-passivated glass slides and coverslips doped with ~1% 
biotinylated mPEG to prevent non-specific sticking of proteins. Preceding each experiment, chambers were 
incubated with 0.2 mg/mL NeutrAvidin (ThermoFisher) for two minutes followed by 10 nM of a 
biotinylated anti-HA antibody (abcam ab26228) for 20-30 min. Following each conjugation step, chambers 
were washed with T50 buffer (50 mM NaCl, 10 mM Tris, pH = 7.5). 
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24-48 hours after transfection of HEK 293T cells, the cells were labeled with 1.5 µM benzylguanine (BG)-
LD555 (Gutzeit et al., 2019) (Qinsi et al., 2017) or SNAP-Surface Alexa Fluor 546 (New England BioLabs) 
in extracellular solution at 37°C for 45 minutes. After labeling, cells were washed in extracellular solution 
to remove excess dye. Next, cells were transferred to Ca2+-free PBS for 20 minutes to dissociate cells from 
coverslips. Cells were then completely removed from coverslips by gentle pipetting. Centrifugation was 
used to pellet cells (16,000 g for 1 minute) before lysis in buffer containing 10 mM Tris, 150 mM NaCl, 1 
mM EDTA, protease inhibitor cocktail, and 1.2% IGEPAL (Sigma), pH = 8.0. After 1 hour of lysis at 4°C, 
cells were centrifuged at 16,000 g for 20 minutes. Next, the supernatant was collected and kept on ice. 
During experiments, the cell lysate was diluted in a 0.1% detergent dilution buffer to achieve sparse 
immobilization of fluorophore-labeled protein on the passivated slide. Protein was added to the slide until 
an optimal density was reached and then the flow chamber was washed with dilution buffer to remove 
unbound protein. For experiments with ligands, drugs were added to cells after dye labeling (during 
dissociation step in Ca2+-free PBS) and maintained throughout the entire experiment at saturating 
concentration. 
Single molecule imaging was conducted with a 100x objective on an inverted microscope (Olympus IX73) 
in total internal reflection fluorescence (TIRF) mode. Movies were recorded with a scMOS camera 
(Hamamatsu ORCA-Flash4v3.0) at 20 Hz with 50 ms exposure. The fluorophores were excited with a 561 
nm laser. Multiple independent experiments were performed for each condition tested, including at least 
two separate transfections and protein preparations. LabVIEW was used for data analysis as previously 
described (Ulbrich and Isacoff, 2007).  
Sequence Conservation Analysis 
mGluR amino acid sequences were obtained from UniProt and aligned using the Multiple Sequence 
Alignment tool from Clustal Omega. Conservation is defined by the chemical characteristics of the amino 
acid side chain (R group): aliphatic (glycine, alanine, valine, leucine, isoleucine); hydroxyl or sulfur-
containing (serine, cystine, threonine, methionine); cyclic (proline); aromatic (phenylalanine, tyrosine, 
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tryptophan); basic (histidine, lysine, arginine); acidic and their amides (aspartate, glutamate, asparagine, 
glutamine).  
Homology modeling 
An initial model of the transmembrane domain of inactive rat mGluR2 was obtained by homology modeling 
using the MODELLER 9.19 software (Sali and TL, 1993) and the 2.2 Å X-ray crystal structure of inactive 
mGluR5 (PDB ID: 6FFI (Christopher et al., 2019)) as a structural template. Missing atomic coordinates of 
extracellular loop 2 (EC2; residues 707-710 of rat mGluR2) were taken from PDB ID 6FFH (Christopher 
et al., 2019) whereas missing atomic coordinates of intracellular loop 2 (IC2; residues 669-674 of rat 
mGluR2) were generated ab initio and selected according to the lowest MODELLER DOPE score (Shen 
and Sali, 2006). To minimize differences in the modeled IC2 region between mGlu2 and mGluR3, an 
inactive rat mGluR3 homology model was obtained using the aforementioned mGluR2 model as a structural 
template and the Prime 5.9 software (Jacobson et al., 2002, MP et al., 2004).  
Coarse-grained molecular dynamics simulations 
Coarse-grained (CG) representations of mGluR2 and mGluR3 inactive models were obtained using the 
martinize.py script within the MARTINI 2.2 force field (de Jong et al., 2013). To preserve the tertiary 
structure of the two receptors, an elastic network was applied to pairs of backbone beads whenever the 
distance between the pairs was smaller than 0.9 nm. A larger force constant of 1000 kJ mol-1 nm-2 was 
applied to pairs of beads within helical secondary structures whereas loop regions were kept more flexible 
with a force constant of 250 kJ mol-1 nm-2. Two CG copies of the same receptor were placed in a 15 × 15 
× 11 nm3 simulation box at a distance of 4.5 or 5.5 nm from each other. Each protomer was then rotated 
randomly around the axis perpendicular to the membrane plane (z-axis) to generate multiple starting 
configurations of neighboring protomers. Each pair of protomers was then embedded in a POPC membrane 
(~635 lipids) and solvated with water molecules and NaCl (0.15 M plus neutralizing ions) using the INSert 
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membrANE (insane) method (Wassenaar et al., 2015). In total, 90 systems were generated for mGluR2 and 
92 for mGluR3. 
Each system was energy minimized and then equilibrated in five steps. First, a 400 ns MD simulation was 
run using position restraints on the backbone beads of the receptor with a force constant of 1000 kJ mol-1 
nm-2. Four additional equilibration steps followed, each of which ran for 60 ns and with position restraints 
applied with decreasing force constants of 500, 100, 50 and 10 kJ mol-1 nm-2, respectively. These MD 
equilibration simulations used the velocity-rescale thermostat (Bussi et al., 2007) and the Berendsen 
algorithm (Eslami et al., 2008) to maintain constant temperature at 310 K and pressure at 1 bar, respectively. 
Production MD runs of 3 or 6 𝜇s (depending on the shorter or longer distance between protomers in the 
initial configuration) for each system, amounting to 450 𝜇s of simulation time for mGluR2 and 462 𝜇s for 
mGluR3, were then carried out in the NPT ensemble at 310K and 1 bar using the velocity-rescale thermostat 
(Bussi et al., 2007) and the Parrinello-Rahman pressure coupling scheme (Parrinello and Rahman, 1998) 
respectively and using an integration timestep of 30 fs. The Coulombic and van der Waals interactions both 
were set to decay to zero between 0 and 1.2 nm (Coulombic) and 0.9 and 1.2 nm (van der Waals). All 
simulations were performed using the GROMACS 2020.4 software package.  
Markov State Model Analysis 
The relative position of two protomers of mGluR2 or mGluR3 was characterized by calculating the number 
of residues in each helix and loop on one protomer formed with the other protomer. Contacts were defined 
by a cutoff of 10 Å on the minimal distance over the beads of the residue. Each simulation frame was then 
classified using a label that contained the domain names of each protomer that formed more than 20 contacts 
with the other protomer. This classification yielded ~2,400 and ~1,700 microstates for the mGluR2 and 
mGluR3 simulations, respectively. Trajectory frames thus clustered were used to estimate a MSM with a 
lag time of 𝜏 = 20	ns, identified after inspecting the change of the transition matrix eigenvalues for 
increasing lag times. The resulting transition matrix was used in the PCCA+ algorithm (Röblitz and Weber, 
2013) to aggregate the microstates into a number of putative biologically relevant macrostates identified by 
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a gap in the characteristic relaxation timescales.  Macrostate equilibrium probabilities 𝜋! = ∑ 𝜋" 	"∈!  were 
calculated summing the probabilities of the corresponding microstates. To label each macrostate, we 
calculated the probability that each helix be at the interface by summing the conditional probabilities that a 
helix 𝐷 is present for protomer 𝛼 in the label ℓ"
(%) of a microstate 𝑖 in the macrostate 𝐼: 







Helices with a probability of at least 40% to be at the interface were reported in the macrostate label.  
Coarse-grained reactive flux between pairs of macrostates was calculated using Transition Path Theory, 
aggregating asymmetric macrostates that correspond to the same interface but with swapped protomers. I 
supplemental table XX, microstates were aggregated if (a) their labels ℓ"
(%)	contained the same helices, but 





(%).  Macrostate contact matrices between domain 𝐷 on the first protomer and 𝐷′ on the second protomer 
〈𝐶((,〉! = ∑ 𝜌"(𝐼)〈𝐶((,〉""  were calculated by averaging the microstate contacts using the PCCA+ cluster 
memberships 𝜌. Contact probabilities between each microstate were defined as averages over the microstate 
frames using a cutoff of 0.9 nm. Fitting of the Markov Models was carried out using the pyEmma library, 
version 2.5.7 (Scherer et al., 2015). 
Steered molecular dynamics simulations 
A model of the dimeric full-length inactive rat mGluR2 was generated by homology modeling using the 
MODELLER 9.19 software (Sali and TL, 1993). The 4 Å electron microscopy structure of inactive mGluR5 
(PDB ID: 6N52 (Christopher et al., 2019)) was used as a template for the extracellular domain (ECD) and 
extracellular loop 2. The rest of the TMD was modeled based on the 2.2 Å X-ray crystal structure of inactive 
mGluR5 (PDB ID: 6FFI (Christopher et al., 2019)) or generated ab initio (IC2), similarly to what was done 
for the TMD models. Just as for the aforementioned TMD systems, a homology model of inactive rat 
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mGluR3 was obtained using the dimeric full-length mGluR2 model as a structural template and the Prime 
5.9 software (Jacobson et al., 2002, MP et al., 2004). 
As reported for the TMD-only models, CG representations of mGluR2 and mGluR3 full-length models 
were obtained with the martinize.py script within the MARTINI 2.2 force field (de Jong et al., 2013) and 
the same criteria for the elastic network was enforced to preserve the tertiary structure of the receptors. The 
full-length dimers were placed in a 1000 × 1000 × 1000nm3 simulation box, respectively, and minimized 
in gas phase with a pseudo-PBC approach (Konermann et al., 2018). Briefly, non-bonded interactions were 
calculated using periodic boundary conditions and the Verlet neighbor search scheme, with the Coulomb 
and Lennard-Jones cutoffs set to 333.3 nm. To preserve the ECD dimeric interface configuration and its 
orientation relative to the TMD, additional positional restraints were imposed on the LBD (1000 kJ mol-1 
nm-2 on the x-, y-, and z-coordinates), the CRD (100 kJ mol-1 nm-2 on the z-coordinates), and the TMD (100 
kJ mol-1 nm-2 on the z-coordinates). 
Target configurations for the steered simulations were generated from the most probable dimers identified 
by the MSM analysis of the TMD-only simulations. Pairwise receptor configurations containing a given 
dimeric interface in the TMD systems were clustered based on the root mean squared deviation (RMSD) 
of the participating domains. The least different configurations from all the others for a particular interface 
was used as a reference to align the protomers of the full-length homology models, so that they could be 
used as target structures. Steered MD simulations were carried out using the GROMACS 2020.4 software 
package patched with PLUMED 2.7 (Tribello et al., 2014). Starting from the full-length homology models, 
the systems were steered over 5,000 steps with a spring constant of 750 kJ mol-1 nm-2 for the harmonic 
potential pulling the system along a collective variable defined by the RMSD of the transmembrane 
backbone beads to the target structures, using the MOVINGRESTRAINT algorithm in PLUMED. In total, 
30 steered simulations were carried out for each interface. Relative free energy estimates were calculated 
by comparing the work obtained applying Jarzynski’s equality (Jarzynski, 1997) to the different 
simulations. 
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Calcium Imaging  
24-48 hours after transfection, cells were imaged at room temperature in extracellular solution composed 
of 135 mM NaCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH = 7.4. Experiments were 
conducted on an inverted microscope (Olympus IX73) and imaged with a 20x objective. A continuous 
gravity-driven perfusion was used throughout the entirety of experiments. GCaMP6f was excited using a 
488 nm laser and movies were recorded using a scMOS camera (Hamamatsu ORCA-Flash4v3.0) at 1 Hz 
with a 100 ms exposure time. Olympus cellSens software was used to select regions of interest (ROIs) 
(representing single cells or small clusters of 2-3 cells) and subsequent data analysis was performed in 
Microsoft Excel, in which fluorescence intensities were normalized to a baseline of extracellular solution 
without drug. ~30 ROIs were analyzed per movie. Glutamate responses were quantified by comparing the 
response to saturating (1 mM) glutamate. PAM responses were also quantified relative to 1 mM glutamate 
responses. Concentration-response curves were fit using Graphpad Prism. Multiple independent 
experiments were performed for each construct tested, including at least two separate transfections.  
Live-cell FRET measurements  
24-48 hours after transfection, cells were washed in extracellular solution containing 135 mM NaCl, 5.4 
mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH = 7.4. For inter-LBD FRET experiments, cells 
were labeled with 1 µM benzylguanine LD555 and 3 µM benzylguanine LD655 (diluted in extracellular 
solution). For inter-TMD FRET experiments with HaloTag constructs, cells were labeled with 1 µM JF 549 
and 3 µM JF 646 (diluted in extracellular solution). All conditions were labeled for 45 minutes at 37 °C. 
Following labeling, coverslips were washed in extracellular solution to remove excess dye. Next, coverslips 
were imaged with a 60x objective on an inverted microscope (Olympus IX73). The donor fluorophore was 
excited with a 561 nm laser and images were recorded at the same time in both donor and acceptor channels 
on distinct scMOS cameras (Hamamatsu ORCA-Flash4v3.0) at 0.5-1 Hz with an exposure time of 100 ms. 
ImageJ was used to analyze cell clusters and FRET was calculated as FRET = (IAcceptor)/(IDonor + IAcceptor), in 
which I = fluorescence intensity. Analysis was restricted to relative FRET changes between drug 
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applications rather than absolute FRET values. For each individual trace, FRET was normalized to the basal 
FRET value observed before drug treatment. For glutamate concentration-response curves, FRET changes 
were calculated by normalizing to saturating glutamate applied in the same recording. For all concentration-
response curves, data was obtained from multiple cell clusters and averaged from at least two separate 
experiments. All concentration-response curves were fit using Prism (Graphpad). For basal activity 
measurements, FRET responses to saturating (5 µM) LY34 were normalized to saturating (100 µM) 
glutamate. A gravity-driven perfusion system was used to deliver drugs diluted in extracellular solution and 
all experiments were performed at room temperature.  
Patch Clamp Electrophysiology 
Whole cell patch clamp recordings from HEK 293T cells co-transfected with GIRK channels were 
performed as previously described (Gutzeit et al., 2019). 
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Figure 1. mGluR2 and mGluR3 transmembrane domains show different dimerization propensities 
in a single molecule pulldown assay  
 
(A) Left, cartoons of SNAP-mGluR2-TMD (top) and SNAP-mGluR3-TMD (bottom) labeled with 
fluorophore LD555. Right, representative images showing expression and surface labeling of SNAP-
mGluR2-TMD (top) and SNAP-mGluR3-TMD (bottom) in HEK 293T cells before lysis.  
(B) Top, schematic showing the SiMPull setup. Bottom, representative image of single molecules with 
representative fluorescence time course for an individual protein complex (red circle) demonstrating two-
step photobleaching. Scale bar = 10 µm. 
(C) Histogram summarizing the photobleaching step distribution for SNAP-mGluR2-TMD (n = 1,598 total 
spots from 14 movies) and SNAP-mGluR3-TMD (n = 1,435 total spots from 10 movies). Dashed line on 
both histograms indicates SNAP-mGluR2-TMD photobleaching step distribution. 
(D) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs. * 
indicates statistical significance (unpaired t-tests; for mGluR3 vs. mGluR2-TMD, p = 1.9E-5; for mGluR2-
TMD vs. mGluR3-TMD, p = 1.1E-10; for mGluR3-TMD vs. β2AR, p = 2.4E-8). mGluR2 is not 
significantly different from mGluR3 (unpaired t-test, p = 0.15).  
(E) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs. * 
indicates statistical significance (unpaired t-tests; for mGluR2 vs. mGluR2-C121A, p = 0.010; for mGluR3 
vs. mGluR3-C127A, p = 4.8E-9).  
(F) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs. * 
indicates statistical significance (unpaired t-tests; for mGluR2-C121A vs. mGluR2-C121A-mGluR3TMD, 
p = 4.3E-4; for mGluR3-C127A vs. mGluR3-C127A-mGluR2TMD, p = 1.5E-6). Shaded bars indicate data 
repeated from Figure 1E.  
(G) Schematic illustrating the effect of inter-TMD interactions in mGluR2 and mGluR3 dimer assembly.  
Number of movies analyzed for each condition is shown in parenthesis above each bar. Error bars are s.e.m. 
 
Figure 2. Residues in TM helix 4 mediate differences in inter-TMD interaction between mGluR2 and 
mGluR3  
(A) Homology models of the TMD of mGluR2 (purple) and mGluR3 (grey) showing TM4 (cyan) residues 
of interest in magenta.  
(B) TM4 sequence alignment for mGluR2 and mGluR3.  
(C) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged TMD constructs. 
* indicates statistical significance (unpaired t-tests; for mGluR2-TMD vs. mGluR2-TMD-3xTM4, p = 
9.5E-6; for mGluR3-TMD vs. mGluR3-TMD-3xTM4, p = 1.0E-5).  
(D) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged full-length 
constructs. * indicates statistical significance (unpaired t-test, p = 7.6E-5). SNAP-mGluR2-C121A-
mGluR3TMD is not significantly different from SNAP-mGluR2-C121A-3xTM4 (unpaired t-test, p = 0.85). 
Shaded bars show repeated data from Figure 1D-E. 
(E) Bar graph showing the percentage of spots bleaching in two steps for N-terminally SNAP-tagged 
constructs labeled with LD555. * indicates statistical significance (unpaired t-test, p = 0.00013). SNAP-
mGluR3-C127A-mGluR2TMD is not significantly different from SNAP-mGluR3-C127A-3xTM4 
(unpaired t-test, p = 0.30). Shaded bars show repeated data from Figure 1D-E. Number of movies analyzed 
for each condition is shown in parenthesis above each bar. Error bars are s.e.m. 
 
Figure 3. Differences in TM4 residues mediate different activation properties of mGluR2 and 
mGluR3 
(A) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from a HEK 293T cell expressing mGluR2-3xTM4, a G protein chimera and GCaMP6f.  
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(B) Glutamate calcium imaging concentration response curves for mGluR2 (EC50 = 1.68 ± 0.03 μM) and 
mGluR2-3xTM4 (EC50 = 0.41 ± 0.06). All values are normalized to saturating (1 mM) glutamate. * 
indicates statistical significance (two-way ANOVA, p = 5.2E-10). 
(C) Summary of glutamate EC50 shifts relative to wild type mGluR2 obtained for mGluR2 mutants. * 
indicates statistical significance (two-way ANOVA; for mGluR2 vs. mGluR2-3xTM4, p = 5.2E-10). 
“TM1” = F584I, G587T; “TM5” =A726S, G730I, A733T 
(D) Representative calcium imaging trace showing calcium responses from mGluR3-3xTM4. 
(E) Glutamate calcium imaging concentration response curves for mGluR3 (EC50 = 0.56 ± 0.06) and 
mGluR3-3xTM4 (EC50 = 11.0 ± 0.1). All values are normalized to saturating (1 mM) glutamate. * indicates 
statistical significance (two-way ANOVA, p = 3.6E-10). 
(F) Summary of glutamate EC50 shifts relative to wild type mGluR3 obtained for mGluR3 mutants. * 
indicates statistical significance (two-way ANOVA; for mGluR3 vs. mGluR3-S686A, p = 2.2E-8; for 
mGluR3 vs. mGluR3-F690A, p = 2.6E-14; for mGluR3 vs. mGluR3-G694A, p = 4.8E-10; for mGluR3 vs. 
mGluR3-3xTM4, p = 3.6E-10). 
(G) LY48 calcium imaging concentration response curves for mGluR2 (EC50 = 0.45 ± 0.10) and mGluR2-
3xTM4 (EC50 = 0.27 ± 0.06). mGluR2-3xTM4 has ~17% greater efficacy than mGluR2 at saturating LY48. 
All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance (two-way 
ANOVA, p = 1.3E-7). 
(H) Glutamate calcium imaging concentration response curves for mGluR2 and mGluR2-3xTM4_W (EC50 
= 9.01 ± 0.08). All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance 
(two-way ANOVA, p = 0.00087). 
(I) Glutamate calcium imaging concentration response curves for mGluR3 and mGluR3-3xTM4_W (EC50 
= 186.00 ± 0.27). All values are normalized to saturating (1 mM) glutamate. * indicates statistical 
significance (two-way ANOVA, p = 1.2E-10). 
 
Figure 4. An inter-TMD FRET assay enables detection of inter-TMD conformational dynamics in 
full-length mGluR2 and mGluR3 in live cells 
(A) Top, schematic showing an mGluR2 dimer with a HaloTag inserted into intracellular loop 2 (ICL2). 
and labeled with donor and acceptor fluorophores. Bottom, representative cell images showing donor and 
acceptor channels after donor excitation with a 561 nm laser. Scale bar = 20 µm. 
(B) Representative FRET trace showing donor and acceptor fluorescence intensity (top) during glutamate 
application. A corresponding normalized FRET trace (bottom) shows reversible FRET increases upon 
glutamate stimulation. 
(C) Glutamate FRET concentration response curves for mGluR2 (EC50 = 15.75 ± 0.04) and mGluR3 (EC50 
= 0.23 ± 0.08). All values are normalized to saturating (1 mM) glutamate.    
(D) Application of the negative allosteric modulator MNI 137 partially blocks glutamate-induced FRET 
increases for mGluR2. 
(E) Quantification of saturating LY34 (5 µM) and MNI (10 µM) blockade of glutamate responses in FRET 
and calcium imaging for mGluR2 and mGluR3. * indicates statistical significance (unpaired t-test, for MNI 
inhibition in FRET vs. function for mGluR2, p = 0.0064; for MNI inhibition in FRET vs. function for 
mGluR3, p = 0.013). 
(F) Representative FRET trace shows application of positive allosteric modulator LY48 at a saturating 
concentration induces a smaller FRET response than saturating glutamate for mGluR2. Inset, quantification 
of LY48 response in FRET and calcium imaging for mGluR2. * indicates statistical significance (unpaired 
t-test, p = 0.0033) 
(G) Representative FRET trace showing glutamate titration for mGluR2-3xTM4.  
(H) Glutamate FRET concentration response curves for mGluR2 and mGluR2-3xTM4 (EC50 = 5.39 ± 0.03). 
All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance (two-way 
ANOVA, p value = 1.7E-6).     
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(I) Glutamate FRET concentration response curves for mGluR3 and mGluR3-3xTM4 (EC50 = 0.56 ± 0.10). 
All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance (two-way 
ANOVA, p value = 0.0083).     
(J) Representative FRET trace showing weak sensitivity to LY34 in the absence of glutamate for mGluR3-
3xTM4. 
(K) Summary showing decrease in basal FRET response to LY34 for mGluR3-3xTM4 compared to wild 
type mGluR3. * indicates statistical significance (unpaired t-test, p = 0.0048). 
(L) Representative patch clamp recording showing weak sensitivity to LY34 in the absence of glutamate 
for mGluR3-3xTM4, indicating minimal basal receptor signaling. 
(M) Summary showing decrease in basal activity as assessed by LY34 application in patch clamp 
recordings for mGluR3-3xTM4 compared to wild type mGluR3. * indicates statistical significance 
(unpaired t-test, p = 0.015). The number of cells tested are shown in parentheses. Error bars represent s.e.m. 
 
Figure 5. Testing the role of TM6 in group II mGluR activation 
(A) Left, cryo-EM structure of mGluR5 TMD dimer (PDB: 6N51) with TM4 highlighted in cyan and TM6 
highlighted in pink. The side chain of I791 (I779 in mGluR2, I788 in mGluR3) is shown in green. Right, 
top view. 
(B) Bar graph showing the percentage of spots bleaching in two steps for N-terminally SNAP-tagged 
constructs labeled with LD555. * indicates statistical significance (unpaired t-tests; for mGluR2-TMD vs. 
mGluR2-TMD-I779A, p = 0.0014; for mGluR3-TMD vs. mGluR3-TMD-I788A, p = 0.019). 
(C) Calcium imaging glutamate concentration response curves for mGluR2 and mGluR2-I779A (EC50 = 
18.66 ± 0.80). All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance 
(two-way ANOVA, p = 1.2E-10). 
(D) Glutamate calcium imaging concentration response curves for mGluR3 and mGluR3-I788A (EC50 = 
10.43 ± 0.10). All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance 
(two-way ANOVA, p = 8.2E-10). 
(E) Summary of glutamate EC50 shifts relative to wild type mGluR2 or mGluR3 obtained for their 
respective mutants. * indicates statistical significance (two-way ANOVA; for mGluR2 vs. mGluR2-I779A, 
p = 1.2E-10; for mGluR2 vs. mGluR2-I779W, p = 0.0028; for mGluR2 vs. mGluR2-P778A-I779A, p = 
0.0015; for mGluR3 vs. mGluR3-I788A, p = 8.2E-10). mGluR2-P778A is not significantly different from 
mGluR2 (two-way ANOVA, p = 0.27).  
(F) LY48 calcium imaging concentration response curves for mGluR2 and mGluR2-I779A (EC50 = 5.46 ± 
0.01). mGluR2-I779A has ~31% lower efficacy than mGluR2 at saturating LY48. All values are normalized 
to saturating (1 mM) glutamate. * indicates statistical significance (two-way ANOVA, p = 6.2E-9). 
(G) Glutamate FRET concentration response curve for mGluR2 and mGluR2-I779A (EC50 = 33.63 ± 0.07). 
All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance (two-way 
ANOVA, p = 0.00060).    
(H) Glutamate FRET concentration response curve for mGluR3 and mGluR3-I788A (EC50 = 0.66 ± 0.05). 
All values are normalized to saturating (1 mM) glutamate. * indicates statistical significance (two-way 
ANOVA, p = 0.030).  
 
Figure 6. SiMPull analysis of ligand induced inter-TMD dimer rearrangement 
(A) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. * indicates statistical significance (unpaired t-test, p = 4.5E-5). Shaded bars indicate data is 
repeated from Figures 3C and 7B. 
(B) Bar graph showing the percent change in dimerization compared to no drug conditions for SNAP-
tagged constructs labeled with LD555. * indicates statistical significance (unpaired t-tests; for mGluR2-
TMD-3xTM4 vs. mGluR2-TMD-3xTM4 + TASP, p = 1.4E-5; for mGluR2-TMD-I779A vs. mGluR2-
TMD-I779A + MNI 137, p = 0.0016).  
(C) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. * indicates statistical significance (unpaired t-tests; for mGluR2-C121A vs. mGluR2-C121A-
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I779A, p = 0.00029; for mGluR2-C121A-I779A vs. mGluR2-C121A-3xTM4-I779A, p = 2.8E-6). Shaded 
bars indicate data is repeated from Figures 1E and 3D. 
(D) Bar graph showing the percent change in dimerization compared to no drug conditions for SNAP-
tagged constructs labeled with LD555. * indicates statistical significance (unpaired t-tests; for mGluR2-
C121A-3xTM4 vs. mGluR2-C121A-3xTM4 + TASP, p = 0.00037; for mGluR2-C121A-3xTM4 vs. 
mGluR2-C121A-3xTM4 + Glu, p = 0.00095; for mGluR2-C121A-I779A vs. mGluR2-C121A-I779A + 
MNI 137, p = 0.00088). 
(E) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. * indicates statistical significance (unpaired t-test, p = 8.1E-5). Shaded bars indicate data is 
repeated from Figures 1E and 3E. 
(F) Bar graph showing the percent change in dimerization compared to no drug conditions for SNAP-tagged 
constructs labeled with LD555. * indicates statistical significance (unpaired t-tests; for mGluR3-C127A vs. 
mGluR3-C127A + Glu, p = 0.00060; for mGluR3-C127A-I788A vs. mGluR3-C127A-I788A + LY34, p = 
0.00021). The number of movies analyzed is shown in parentheses. Error bars represent s.e.m.  
(G) Schematic summarizing data indicating that TM4 mediates inactive interfaces which reorient to a TM6 
interface upon activation by PAMs or agonists. 
 
Figure 7. mGluR2/3 heterodimers show intermediate inter-TMD affinity compared to parent 
homodimers. 
(A) Top, schematic of 2-color heterodimer SiMPull experiments where HA-SNAP-mGluR2-TMD (labeled 
with LD655) is able to immobilize with CLIP-mGluR3-TMD (labeled with DY-547). Bottom, 
representative image showing efficient pulldown in both channels, indicative of heterodimerization of 
mGluR2 and mGluR3 TMDs. 
(B) Summary bar graph showing the efficiency of pulldown of either CLIP-mGluR2-TMD or CLIP-
mGluR3-TMD by SNAP-mGluR2-TMD. *** indicates statistical significance (unpaired t-test; p=3.8E-6). 
(C) Top, schematic of 2-color heterodimer SiMPull experiments where HA-SNAP-mGluR3-TMD (labeled 
with LD655) is able to immobilize with CLIP-mGluR2-TMD (labeled with DY-547) via an anti-HA 
antibody. Bottom, representative image showing efficient pulldown in both channels, indicative of 
heterodimerization. 
(D) Summary bar graph showing the efficiency of pulldown of either CLIP-mGluR2-TMD or CLIP-
mGluR3-TMD by SNAP-mGluR2-TMD. ** indicates statistical significance (unpaired t-test; p=0.0097). 
(E) Representative images showing SiMPull of full-length CLIP-mGluR3 by full-length HA-SNAP-
mGluR2. 
(F) Summary bar graph showing efficiency of pulldown of wild type and mutant full-length CLIP-tagged 
mGluR2 and mGluR3 by HA-SNAP-mGluR2. *** indicates statistical significance (unpaired t-tests; for 
mGluR2/mGluR2 vs. mGluR2/mGluR3, p=1.6E-6; for C121A/C121A vs. C121A/C127A, p=1.9E-9; for 
C121A/C127A vs. C121A/C127A-3xTM4, p=1.2E-5). 
(G) Summary bar graph showing efficiency of pulldown of wild type and mutant full-length CLIP-tagged 
mGluR2 and mGluR3 by HA-SNAP-mGluR3. *** indicates statistical significance (unpaired t-tests; for 
C127A/C127A vs. C127A/C121A, p=1.3E-5; for C127A/C121A vs. C127A/C121A-3xTM4, p=0.00081). 
(H) Summary schematic showing relative dimerization propensities of mGluR2, mGluR2/3 and mGluR3 
TMD. 
 
Figure 8. A working model of inter-TMD rearrangement and mGluR activation. 
(A) Four-state working model of inter-TMD rearrangement during mGluR activation. LBD-driven TMD 
dimer formation occurs first, followed by dimer reorientation from TM4-containing to TM6-containing 
interfaces, and intra-subunit conformational changes. Transitions between steps can be differentially 
modulated by orthosteric and allosteric drugs. 
(B) Proposed relative free energy plots along the activation pathway for mGluR2. Inset, TM4 dimer 
interface intermediates likely show differential stabilities across subtypes which tunes the efficiency of 
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activation and the relative basal activity. Multiple local energy minima likely exist within state 2 due to 
distinct inter-TMD dimer interfaces that involve TM4. 
(C) Proposed relative free energy plots for mGluR2 in the absence and presence of agonist and G protein 
showing possible relative stabilizations of states and alterations of energy barriers. Generally, agonist-
binding lowers the barrier between states 1 and 2 and stabilizes TM6 interfaces (states 3 and 4) while G 
protein further stabilizes state 4. It’s important to note that there are likely many microstates and alternative 
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Supplemental Figure Legends: 
 
Figure 1—figure supplement 1. Further characterization of single molecule pulldown of mGluR 
TMDs: lack of subunit exchange in detergent. 
(A) Cartoons of mGluR2-TMD constructs. Left, a SNAP-tagged TMD is labeled with LD655 and has an 
HA tag for antibody pulldown. Right, a CLIP-tagged TMD is labeled with CLIP-Surface 547.  
(B) Schematic of experimental design in which cells are co-transfected with CLIP-mGluR2-TMD and 
SNAP-mGluR2-TMD constructs. 
(C) Schematic of experimental design in which cells are transfected with either CLIP-mGluR2-TMD or 
SNAP-mGluR2-TMD and combined just prior to cell lysis. 
(D) Representative single molecule images of co-transfected HA-SNAP-mGluR2-TMD labeled with 
LD655 (red circled spots) and CLIP-mGluR2-TMD labeled with CLIP-Surface 547 (green circled spots). 
Molecules were imaged with a 640 nm laser (left) and a 561 nm laser (right). Scale bar = 10 µm. 
(E) Representative single molecule images of HA-SNAP-mGluR2-TMD labeled with LD655 (red circled 
spots) and CLIP-mGluR2-TMD labeled with CLIP-547 (green circled spots) mixed prior to cell lysis. 
Molecules were imaged with a 640 nm laser (left) and a 561 nm laser (right). Scale bar = 10 µm. 
(F) Bar graph showing the total number of SNAP- or CLIP-mGluR2-TMD spots for the co-transfected 
condition and the condition in which cells were mixed just prior to lysis. Error bars represent s.e.m. 
 
Figure 1—figure supplement 2. Inter-TMD dimerization propensities are maintained with C-
terminal pulldown of mGluR2 and mGluR3 TMDs 
(A) Top, schematic showing SiMPull strategy with C-terminal pulldown. Bottom, representative single 
molecule images of SNAP-mGluR2-TMD and SNAP-mGluR3-TMD pulled down via the C-terminal 
antibody. Scale bar = 10 µm. 
(B) Bar graph showing that dimer propensities characteristic of SNAP-mGluR2-TMD and SNAP-mGluR3-
TMD are maintained upon C-terminal pulldown. * indicates statistical significance (unpaired t-test, p = 
0.0011). Number of movies analyzed for each condition is shown in parenthesis above each bar. Error bars 
represent s.e.m. 
 
Figure 1—figure supplement 3. Ensemble FRET dequenching measurements show higher levels of 
inter-TMD FRET for mGluR2 compared to mGluR3 
(A) Representative donor and acceptor images of HEK 293T cells before and after acceptor channel 
bleaching for SNAP-mGluR2-TMD. 
(B) Summary bar graph showing a significantly higher donor recovery for mGluR2-TMD compared 
mGluR3-TMD and the prototypical class A GPCR, ß2AR (unpaired t-tests; for ß2AR vs. mGluR2-TMD, p 
= 1.3E-6; for mGluR2-TMD vs. mGluR3-TMD, p = 0.00060). Error bars represent s.e.m. 
 
Figure 1—figure supplement 4. Representative images showing similar expression and single 
molecule pulldown for mGluR2 and mGluR3 cysteine mutant constructs. 
(A) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-C121A and 
SNAP-mGluR3-C127A. Scale bar = 10 µm. 
(B) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-C121A-
mGluR3TMD and SNAP-mGluR3-C127A-mGluR2TMD. Scale bar = 10 µm. 
(C) Quantification of surface expression from HEK 293T cell images shows similar expression between 
constructs. Error bars represent s.e.m. 
 
 
Figure 2—figure supplement 1. mGluR TMD sequence conservation analysis  
(A) Amino acid sequence alignments across the eight mGluR family members for all 7 TMs with outward-
facing residues underlined and shown in purple. 
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(B) Top, homology models of mGluR2-TMD in grey with TM helices highlighted. Bottom left, homology 
models of mGluR2-TMD showing side chains of outward-facing residues in purple. Bottom right, top view 
of model with outward-facing residues.  
(C) Quantification of percent conservation and identity across the 7 TM helices. 
(D) TM4 sequence alignment shows the 3xTM4 motif in mGluR2 and mGluR3 is mostly conserved across 
species.  
 
Figure 2—figure supplement 2. CG MD analysis of mGluR TMD dimerization. 
(A) Coarse-grained (CG) representations of pairs of mGluR2 or mGluR3 simulated in a hydrated POPC 
bilayer.  
(B-C) Reactive flux between the different macrostates identified by the PCCA+ analysis of the MSM 
analysis. Macrostates encompassing asymmetric dimers (i.e., tm1/tm4 and tm4/tm1) have been aggregated 
for the sake of clarity. The size of the nodes is proportional to the probability of each macrostate, and the 
thickness of the edges is proportional to the logarithm of the total reactive flux between the nodes. 
Microstates were defined by labels that contained the names of helices and loops of each protomer that 
formed more than 20 contacts with the other protomer, with contacts defined by a cutoff of 10 Å on the 
minimal distance over the beads of the residue. Total probability and fraction within a macrostate were 
calculated aggregating microstates if their labels contained the same helices but different loops, or if their 
labels were equivalent after swapping protomers. Microstates with total probability above 0.1% and 
macrostate fraction above 0.6% in either mGluR2 or mGluR3 are indicated below as part of the top 
macrostate they belong to for each receptor separately. (B) Reactive flux between the different macrostates 
identified for mGluR2; a consisting of 33.8% microstate (tm1,tm7)/tm4, 18.2% tm3/tm7, 7.9% 
(tm1,tm7)/tm3, 7.9% tm4/tm7, 5.1% (tm3,tm5)/tm7, 5.0% tm1/tm4, 4.5% tm5/tm7, 4.1% tm1/tm3, 3.9% 
tm1/tm5, 1.9% (tm3,tm5)/tm1, 1.5% (tm1,tm7)/(tm3,tm4), 1.0% (tm1,tm7)/(tm3,tm5), 0.6% 
(tm3,tm4)/tm1, 0.4% tm2/tm3, 0.3% tm4/tm4; b consisting of 32.2% microstate (tm1,tm7)/tm5, 8.5% 
(tm1,tm7)/(tm5,tm6), 6.1% tm2/tm5, 3.0% (tm2,tm7)/tm5, 2.4% (tm1,tm5)/tm2, 1.6% (tm5,tm7)/tm7, 
1.0% (tm1,tm2)/(tm5,tm6), 1.0% (tm5,tm7)/tm2, 0.8% (tm5,tm6)/tm1; c consisting of 13.0% microstate 
(tm1,tm7)/(tm1,tm7), 8.8% (tm1,tm7)/tm7, 8.1% tm2/tm7, 6.0% tm7/tm7, 5.1% tm1/tm7, 4.4% 
(tm2,tm7)/tm7, 4.3% tm1/tm1, 3.8% (tm1,tm7)/tm1, 3.5% (tm1,tm2)/(tm1,tm7), 2.6% tm1/tm2, 1.9% 
(tm1,tm2)/tm7, 1.7% (tm2,tm7)/tm2, 1.5% (tm2,tm7)/(tm2,tm7), 1.5% (tm2,tm3)/tm7, 1.3% tm1/tm6, 
1.2% (tm1,tm7)/tm2, 1.1% (tm1,tm2)/tm1, 0.8% (tm1,tm7)/(tm2,tm7), 0.8% (tm1,tm6)/tm1, 0.7% 
(tm3,tm4)/tm7, 0.7% tm2/tm2, 0.6% tm6/tm6, 0.3% (tm1,tm7)/(tm2,tm3); d consisting of 47.5% microstate 
tm3/tm6. (C) Reactive flux between the different macrostates identified for mGluR3; a' consisting of 17.6% 
microstate tm2/tm3, 10.9% tm3/tm7, 9.7% (tm1,tm7)/tm4, 9.1% (tm2,tm7)/tm3, 6.2% (tm1,tm7)/tm3, 
5.2% (tm3,tm5)/tm2, 4.7% tm1/tm4, 4.3% (tm1,tm2)/tm4, 3.8% tm1/tm3, 3.5% (tm2,tm7)/tm4, 2.7% 
(tm3,tm5)/tm7, 2.4% tm4/tm7, 1.5% (tm3,tm5)/tm1, 1.4% (tm2,tm7)/(tm3,tm5), 1.2% (tm3,tm4)/tm1, 
1.1% tm2/tm4, 1.1% (tm1,tm7)/(tm3,tm4), 0.8% (tm1,tm7)/tm2, 0.8% (tm1,tm7)/(tm2,tm3), 0.7% 
(tm2,tm7)/tm5, 0.7% (tm1,tm7)/(tm3,tm5), 0.5% (tm3,tm4)/tm7, 0.4% tm1/tm5, 0.4% tm2/tm5, 0.3% 
(tm2,tm3)/tm7, 0.3% (tm2,tm7)/tm2; b' consisting of 53.7% microstate (tm1,tm7)/(tm1,tm7), 15.1% 
(tm1,tm7)/tm7, 10.7% tm7/tm7, 4.3% tm1/tm7, 3.7% (tm1,tm7)/tm1, 3.3% tm2/tm7, 3.1% tm2/tm2, 1.4% 
(tm1,tm7)/(tm2,tm7), 1.3% (tm1,tm2)/(tm1,tm7), 0.6% (tm2,tm7)/tm7; c' consisting of 32.0% microstate 
tm3/tm4, 20.4% tm4/tm4, 16.0% (tm3,tm5)/tm4, 8.4% tm4/tm5; d' consisting of 56.6% microstate 
(tm1,tm7)/(tm5,tm6), 18.7% (tm5,tm6)/tm1, 8.6% (tm1,tm7)/tm5; e' consisting of 54.8% microstate 
(tm1,tm7)/tm4).  
(D-G) Representative structures of the largest macrostates identified by MSM analysis of simulations of 
mGluR2 ((D) macrostate c, (E) macrostate a, and (F) macrostate b) and mGluR3 ((G) macrostate a’)). 
Representative coarse-grained configurations of the macrostates of mGluR2 or mGluR3 were clustered 
based on the RMSD of the corresponding interfaces. For a given interface, the least different configuration 
from all others was converted into an all-atom model using backward (Wassenaar et al., 2014). Interfacial 
residues within 4 Å are depicted as spheres. TM1: green, TM3: yellow, TM4: cyan, TM5: orange, TM7: 
red. 
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Figure 2—figure supplement 3. Symmetric TM4-TM4 interfaces for group II mGluR TMDs 
(A-B) Representative structures of TM4-TM4 dimeric microstates for mGluR2 (A) and mGluR3 (B) 
showing conserved residues (cyan) at the cytosolic end that differ between subtypes. 
 
Figure 2—figure supplement 4. Further analysis of dimerization of TM4 mutants of mGluR2 and 
mGluR3 TMD constructs. 
(A) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-TMD-3xTM4 
and SNAP-mGluR3-TMD-3xTM4. Scale bar = 10 µm. 
(B) Quantification of surface expression from HEK 293T cell images shows similar expression between 
constructs.  
(C) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Single TM4 mutant constructs alter SNAP-mGluR2-TMD or SNAP-mGluR3-TMD 
dimerization. * indicates statistical significance (unpaired t-tests; for mGluR2-TMD vs. mGluR2-TMD-
A677S, p = 0.0029; for mGluR2-TMD vs. mGluR2-TMD-A681F, p = 0.0059; for mGluR2-TMD vs. 
mGluR2-TMD-A685G, p = 0.00013; for mGluR3-TMD vs. mGluR3-TMD-S686A, p = 0.00041; for 
mGluR3-TMD vs. mGluR3-TMD-F690A, p = 0.0048; for mGluR3-TMD vs. mGluR3-TMD-G694A, p = 
0.029). Number of movies analyzed for each condition is in parenthesis above each bar. Error bars represent 
s.e.m. 
(D) Representative HEK 293T cell images of single TM4 mutant constructs. Scale bar = 10 µm. 
 
Figure 2—figure supplement 5. TM1 and TM5 mutants do not alter TMD dimerization or function 
of mGluR2. 
(A) Top left, homology model of mGluR2-TMD showing side chains of residues of interest in magenta. 
Top right, top view. Bottom, sequence alignment of TM4 residues in mGluR2 and mGluR3 showing 
outward-facing residues underlined and in purple.  
(B) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. The mutations to TM4 do not alter dimerization compared to wild-type mGluR2-TMD 
(unpaired t-test, p = 0.67). 
(C) Top left, cartoon model of mGluR1-TMD (PDB: 4OR2) showing side chains of residues of interest in 
blue and green. Top right, top view. Bottom, sequence alignment of TM1 residues in mGluR2 and mGluR3 
showing outward-facing residues underlined and in purple.  
(D) Top left, cartoon model of mGluR5-TMD (PDB: 6N52) showing side chains of residues of interest in 
red, orange and yellow. Top right, top view. Bottom, sequence alignment of TM5 residues in mGluR2 and 
mGluR3 showing outward-facing residues underlined and in purple.  
(E) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. The mutations to TM1 and TM5 do not alter dimerization compared to wild-type mGluR2-
TMD (unpaired t-tests; for mGluR2-TMD vs. mGluR2-TMD-F584I-G587T, p = 0.14; for mGluR2-TMD 
vs. mGluR2-TMD-A726S-G730I-A733T, p = 0.38). Number of movies analyzed for each condition is 
shown in parenthesis above each bar. Error bars represent s.e.m. 
 
Figure 2—figure supplement 6. Further analysis of dimerization of TM4 mutants of mGluR2 and 
mGluR3 TMD constructs. 
(A) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-mGluR3TMD 
and SNAP-mGluR3-mGluR2TMD. Scale bar = 10 µm. 
(B) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-3xTM4 and 
SNAP-mGluR3-3xTM4. Scale bar = 10 µm. 
(C) Representative HEK 293T cell images and single molecule images of SNAP-mGluR2-C121A-3xTM4 
and SNAP-mGluR3-C127A-3xTM4. Scale bar = 10 µm. 
(D) Quantification of surface expression from HEK 293T cell images shows similar expression between 
constructs.  
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(E) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. TMD chimera constructs and 3xTM4 mutant constructs do not alter dimerization of SNAP-
mGluR2 or SNAP-mGluR3 (unpaired t-tests; for SNAP-mGluR2 vs. SNAP-mGluR2-mGluR3TMD, p = 
0.085; for SNAP-mGluR2 vs. SNAP-mGluR2-3xTM4, p = 0.14; for SNAP-mGluR3 vs. SNAP-mGluR3-
mGluR2TMD, p = 0.27; for SNAP-mGluR3 vs. SNAP-mGluR3-3xTM4, p = 0.37). Number of movies 
analyzed for each condition is shown in parenthesis above each bar. Error bars represent s.e.m. 
 
Figure 3—figure supplement 1. Differences in TM4 residues mediate different activation properties 
of mGluR2 and mGluR3. 
(A) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from HEK 293T cells expressing mGluR2, a Gaqi protein chimera and GCaMP6f.  
(B) Glutamate calcium imaging concentration response curves for mGluR2 (EC50 = 1.68 ± 0.03 μM) and 
mGluR3 (EC50 = 0.56 ± 0.06). All values are normalized to saturating (1 mM) glutamate. * indicates 
statistical significance (two-way ANOVA, p = 6.4E-5). 
(C) Glutamate calcium imaging concentration response curves for mGluR2 and TM4 mutants mGluR2-
A677S (EC50 = 1.94 ± 0.03), -A681F (EC50 = 1.79 ± 0.03), -A685G (EC50 = 2.01 ± 0.06). The mutants do 
not significantly differ from wild-type mGluR2 (two-way ANOVA; for mGluR2 vs. mGluR2-A677S, p = 
0.96; for mGluR2 vs. mGluR2-A681F, p = 0.81; for mGluR2 vs. mGluR2-A685G, p = 0.64).  
(D) Glutamate calcium imaging concentration response curves for mGluR3 and TM4 mutants mGluR3-
S686A (EC50 = 5.12 ± 0.06), -F690A (EC50 = 9.59 ± 0.06), -G694A (EC50 = 4.66 ± 0.03). * indicates 
statistical significance (two-way ANOVA; for mGluR3 vs. mGluR3-S686A, p = 2.2E-8; for mGluR3 vs. 
mGluR3-F690A, p = 2.6E-14; for mGluR3 vs. mGluR3-G694A, p = 4.9E-10). 
(E) Glutamate calcium imaging concentration response curves for mGluR2 and TM1 mutant mGluR2-
F584I-G587T (EC50 = 2.50 ± 0.06) and TM5 mutant mGluR2-A726S-G730I-A733T (EC50 = 2.05 ± 0.10). 
All values are normalized to saturating (1 mM) glutamate. The mutants do not significantly differ from 
wild-type mGluR2 (two-way ANOVA; for mGluR2 vs. mGluR2-F584I-G587T, p = 0.29; for mGluR2 vs. 
mGluR2-A726S-G730I-A733T, p = 0.71).  
(F) Representative calcium imaging trace showing calcium responses induced by LY487379 and glutamate 
application from HEK 293T cells expressing mGluR2, a Gaqi protein chimera and GCaMP6f. 
(G) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. * indicates statistical significance (unpaired t-test, p = 4.7E-8). mGluR3-TMD is not 
significantly different from mGluR3-TMD-3xTM4_W (unpaired t-test, p = 0.85).  
(H) Representative single molecule images of SNAP-mGluR2-TMD-3xTM4_W and SNAP-mGluR3-
TMD-3xTM4_W and representative HEK 293T cell images of SNAP-mGluR2-3xTM4_W and SNAP-
mGluR3-3xTM4_W. Scale bar = 10 µm. 
(I) Quantification of surface expression from HEK 293T cell images shows similar expression between 
constructs. 
 
Figure 4—figure supplement 1. Differences in TM4 residues do not alter inter-LBD conformational 
dynamics 
(A) Representative LBD FRET trace showing FRET decreases in response to glutamate application.  
(B) Glutamate LBD FRET concentration response curves for mGluR2 (EC50 = 11 ± 0.02), mGluR2-3xTM4 
(EC50 = 11 ± 0.02), mGluR3 (EC50 = 0.64 ± 0.10) and mGluR3-3xTM4 (EC50 = 0.67 ± 0.05). All values are 
normalized to saturating (1 mM) glutamate. The mutants do not differ from their wild-type counterparts 
(two-way ANOVA; for mGluR2 vs. mGluR2-3xTM4, p = 0.17; for mGluR3 vs. mGluR3-3xTM4, p = 
0.60).  
(C) Representative mGluR2-3xTM4 LBD FRET trace showing a FRET response induced by glutamate 
application and no change induced by antagonist LY34 application. 
(D) Quantification of LBD basal FRET. Error bars represent s.e.m. 
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Figure 4—figure supplement 2. Characterization of inter-TMD FRET sensor in mGluR2 and 
mGluR3. 
(A) Bar graph showing that 1:3 donor:acceptor dye labeling is the optimal ratio to detect FRET changes for 
the inter-TMD FRET sensor. * indicates statistical significance (unpaired t-tests; for 1:2 vs. 1:3, p = 0.0023; 
for 1:3 vs. 1:5, p = 0.011). 
(B) Representative FRET trace shows stability of signal over a 2-minute glutamate application. 
(C) Bar graph showing maximum FRET change from saturating glutamate observed for mGluR2 compared 
to mGluR3. * indicates statistical significance (unpaired t-test, p = 0.00066). 
(D) A FRET change does not occur when only donor dye (JF 549) is labeled. 
(E) A FRET change does not occur when only acceptor dye (JF 646) is labeled. 
 
Figure 4—figure supplement 3. Characterization of inter-TMD conformational dynamics in response 
to orthosteric and allosteric drugs. 
(A) Representative FRET trace for mGluR3 shows concentration-dependent glutamate responses. 
(B) Representative FRET trace for mGluR2 shows concentration-dependent glutamate responses.  
(C) Representative FRET trace for mGluR2 shows application of antagonist LY34 blocks a glutamate-
induced FRET response. 
(D) Representative FRET trace for mGluR3 shows application of antagonist LY34 blocks a glutamate-
induced FRET response. 
(E) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from a HEK 293T cell expressing mGluR2, a G protein chimera and GCaMP6f. A second glutamate 
application is blocked by application of antagonist LY34.  
(F) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from a HEK 293T cell expressing mGluR3, a G protein chimera and GCaMP6f. A second glutamate 
application is blocked by application of antagonist LY34. 
(G) Representative FRET trace for mGluR3 shows application of negative allosteric modulator MNI 137 
partially blocks a glutamate-induced FRET response. 
(H) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from a HEK 293T cell expressing mGluR2, a G protein chimera and GCaMP6f. A second glutamate 
application is blocked by application of negative allosteric modulator MNI 137. 
(I) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from a HEK 293T cell expressing mGluR3, a G protein chimera and GCaMP6f. A second glutamate 
application is blocked by application of negative allosteric modulator MNI 137. 
(J) Quantification of basal inter-TMD FRET response upon LY34 or MNI 137 application in mGluR3-
Halo-ICL2. * indicates statistical significance (unpaired t-test, p = 0.00043). 
(K) Representative patch clamp recording showing sensitivity in response to LY34 application in the 
absence of glutamate for mGluR3, indicating basal receptor signaling. 
(L) Quantification of basal activity in patch clamp recordings shows no significant difference between 
LY34 and MNI 137. 
 
Figure 5—figure supplement 1. Further characterization of TM6 in mGluR activation.  
(A) Representative HEK 293T cell images of mGluR2 TM6 mutants. Scale bar = 10 µm. 
(B) Quantification of surface expression from HEK 293T cell images shows similar expression between 
constructs.  
(C) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. * indicates statistical significance (unpaired t-tests; for SNAP-mGluR2-TMD vs. SNAP-
mGluR2-TMD-I779A, p = 0.00074; for SNAP-mGluR2-TMD vs. SNAP-mGluR2-TMD-I779W, p = 
0.00038; for SNAP-mGluR2-TMD vs. SNAP-mGluR2-TMD-P778A, p = 0.00047; for SNAP-mGluR2-
TMD vs. SNAP-mGluR2-TMD-P778A-I779A, p = 6.4E-5). Number of movies analyzed for each condition 
is shown in parenthesis above each bar. Error bars represent s.e.m. 
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(D) Glutamate calcium imaging concentration response curves for mGluR2 and TM6 mutants mGluR2-
I779A (EC50 = 18.66 ± 0.08), -I779W (EC50 = 4.37 ± 0.04), -P778A (EC50 = 0.85 ± 0.1), -P778A-I779A 
(EC50 = 5.09 ± 0.08). * indicates statistical significance (two-way ANOVA; for mGluR2 vs. mGluR2-
I779A, p = 1.2E-10; for mGluR2 vs. mGluR2-I779W, p = 0.003; for mGluR2 vs. mGluR2-P788A-I779A, 
p = 0.0015). mGluR2-P788A is not significantly different from mGluR2 (two-way ANOVA, p = 0.27). 
(E) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from HEK 293T cells expressing mGluR2-I779A, a G protein chimera and GCaMP6f.  
(F) Representative calcium imaging trace showing calcium responses induced by glutamate application 
from HEK 293T cells expressing mGluR3-I788A, a G protein chimera and GCaMP6f.  
(G) Representative FRET trace for mGluR2-I779A. 
(H) Representative FRET trace for mGluR3-I788A. 
 
Figure 6—figure supplement 1. Analysis of ligand induced inter-TMD rearrangement by SiMPull.  
(A) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of PAM or NAM does not alter mGluR2-TMD dimerization (unpaired t-test; for 
mGluR2-TMD vs. mGluR2-TMD + TASP, p = 0.87; for mGluR2-TMD vs. mGluR2-TMD + MNI 137, p 
= 0.96).  
(B) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of PAM significantly increases dimerization for mGluR2-TMD-3xTM4 
compared to no drug and NAM conditions. * indicates statistical significance (unpaired t-test; for mGluR2-
TMD-3xTM4 vs. mGluR2-TMD-3xTM4 + TASP, p = 5.6E-7; for mGluR2-TMD-3xTM4 + TASP vs. 
mGluR2-TMD-3xTM4 + MNI 137, p = 0.0011).  
(C) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of NAM significantly increases dimerization for mGluR2-TMD-I779A compared 
to no drug and NAM conditions. * indicates statistical significance (unpaired t-test; for mGluR2-TMD-
I779A + TASP vs. mGluR2-TMD-I779A + MNI 137, p = 0.0017). mGluR2-TMD-I779A is not 
significantly different from mGluR2-TMD-I779A + TASP (unpaired t-test, p = 0.40). 
(D) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of PAM or NAM does not alter mGluR2-TMD-3xTM4-I779A dimerization 
(unpaired t-tests; for mGluR2-TMD-3xTM4-I779A vs. mGluR2-TMD-3xTM4-I779A + TASP, p = 0.86; 
for mGluR2-TMD-3xTM4-I779A vs. mGluR2-TMD-3xTM4-I779A + MNI 137, p = 0.25).  
(E) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of ligand does not alter mGluR2-C121A dimerization (unpaired t-test; for 
mGluR2-C121A vs. mGluR2-C121A + TASP, p = 0.56; for mGluR2-C121A vs. mGluR2-C121A + MNI 
137, p = 0.97; for mGluR2-C121A vs. mGluR2-C121A + Glu, p = 0.44).  
(F) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of PAM and glutamate significantly increases dimerization for mGluR2-C121A-
3xTM4 compared to no drug and NAM conditions. * indicates statistical significance (unpaired t-tests; for 
mGluR2-C121A-3xTM4 vs. mGluR2-C121A-3xTM4 + TASP, p = 0.0016; for mGluR2-C121A-3xTM4 + 
TASP vs. mGluR2-C121A-3xTM4 + MNI 137, p = 0.00086; for mGluR2-C121A-3xTM4 + MNI 137 vs. 
mGluR2-C121A-3xTM4 + Glu, p = 0.0013).  
(G) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of NAM significantly increases dimerization for mGluR2-C121A-I779A 
compared to no drug, PAM, and glutamate conditions. * indicates statistical significance (unpaired t-test; 
for mGluR2-C121A-I779A vs. mGluR2-C121A-I779A + TASP, p = 0.19; for mGluR2-C121A-I779A + 
TASP vs. mGluR2-C121A-I779A + MNI 137, p = 4.5E-5; for mGluR2-C121A-I779A + MNI 137 vs. 
mGluR2-C121A-I779A + Glu, p = 0.00093).  
(H) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of ligand does not alter mGluR2-C121A-3xTM4-I779A dimerization (unpaired 
t-tests; for mGluR2-C121A-3xTM4-I779A vs. mGluR2-C121A-3xTM4-I779A + TASP, p = 0.33; for 
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mGluR2-C121A-3xTM4-I779A vs. mGluR2-C121A-3xTM4-I779A + MNI 137, p = 0.88; for mGluR2-
C121A-3xTM4-I779A vs. mGluR2-C121A-3xTM4-I779A + Glu, p = 0.79).  
(I) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of glutamate significantly increases dimerization for mGluR3-C127A compared 
to no drug and LY34 conditions. * indicates statistical significance (unpaired t-test, p = 8.8E-5). Application 
of LY34 did not alter dimerization compared to the no drug condition (unpaired t-test, p = 0.24).  
(J) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of ligand does not alter mGluR3-C127A-3xTM4 dimerization (unpaired t-tests; 
for mGluR3-C127A-3xTM4 vs. mGluR3-C127A-3xTM4 + LY34, p = 0.78; for mGluR3-C127A-3xTM4 
vs. mGluR3-C127A-3xTM4 + Glu, p = 0.38).  
(K) Bar graph showing the percentage of spots bleaching in two steps for SNAP-tagged constructs labeled 
with LD555. Application of LY34 significantly increases dimerization for mGluR3-C127A-I788A 
compared to no drug and glutamate conditions. * indicates statistical significance (unpaired t-tests; for 
mGluR3-C127A-I788A vs. mGluR3-C127A-I788A + LY34, p = 0.00053; for mGluR3-C127A-I788A + 
LY34 vs. mGluR3-C127A-I788A + Glu, p = 0.00065). Number of movies analyzed for each condition is 
shown in parenthesis above each bar. Error bars represent s.e.m. 
 
Figure 7-figure supplement 1. Further analysis of homo- and hetero-dimerization propensities of 
isolated group II mGluR TMDs. 
(A) Representative images showing fluorophore labeled receptors on the surface of HEK 293T cells. 
(B) Quantification of fluorescence intensities across co-expression conditions showing comparable 
expression conditions used for 2-color SiMPull analysis.  
(C) Representative SiMPull images showing background levels of pulldown from lysates containing only 
CLIP-tagged constructs lacking an HA tag. 
(D) Quantification of the number of immobilized spots for a representative experiment showing that SNAP-
mGluR2-TMD is able to pull down a substantially higher amount of CLIP-mGluR2-TMD than CLIP-
mGluR3-TMD. Background values for the CLIP construct expressed alone for each condition are shown 
as black bars. 
(E) Same as (A-D) but with SNAP-mGluR3-TMD conditions. 
 
Figure 7-figure supplement 2. Further analysis of homo- and hetero-dimerization propensities of 
isolated full-length group II mGluRs. 
(A) Quantification of fluorescence intensities across co-expression conditions showing comparable 
expression conditions used for 2-color SNAP-mGluR2 SiMPull analysis.  
(B) Quantification of the number of immobilized spots for a representative SNAP-mGluR2 SiMPull 
experiment. Background values for the CLIP construct expressed alone for each condition are shown as 
black bars. 
(C) Quantification of fluorescence intensities across co-expression conditions showing comparable 
expression conditions used for 2-color SNAP-mGluR3 SiMPull analysis. 
(D) Quantification of the number of immobilized spots for a representative SNAP-mGluR3 SiMPull 
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